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ABSTRACT OF DISSERTATION 
 
 
 
 
 
OUTCOMES ASSOCIATED WITH BLOOD COMPONENT TRANSFUSION IN 
ADULT TRAUMA PATIENTS 
 
 The purpose of this dissertation was to evaluate outcomes associated with blood 
component (BC) transfusion in adult trauma patients. Specific aims were to: 1) explore 
the relationship between traumatic injury, hemorrhage, and BC transfusion, focusing on 
consequences of the component storage lesion through presentation of a conceptual 
model; 2) systematically review research literature comparing outcomes of massively 
transfused major trauma patients based on ratios of BCs received; 3) evaluating the 
relationship between type of blood transfusion trauma patients received (whole blood 
versus BCs) and mortality likelihood after controlling for demographic and clinical 
variables; 4) evaluating the relationship between volume and ratio of BCs transfused to 
trauma patients and development of inflammatory complications (ICs) after controlling 
for demographic and clinical variables. 
 Specific aim one was addressed through the development of a conceptual model, 
depicting the current state of knowledge regarding the storage lesion, and short-/long-
term outcomes of traumatic injury, hemorrhage, and blood transfusion. The second 
specific aim was addressed through a systematic review of studies that grouped critically 
injured, massively transfused patients based on ratios of BCs they received, and 
compared clinical outcomes among groups. Findings from this analysis revealed 
increased survival likelihood with massive transfusion of BCs in a 1:1:1 (packed red 
blood cells [PRBCs], fresh frozen plasma [FFP], platelets [PLTs]) fashion. The third 
specific aim involved a secondary analysis of the National Trauma Data Bank to evaluate 
the relationship between type of transfusion trauma patients received (whole blood versus 
BCs) and mortality. Patients who received BCs experienced a higher mortality likelihood 
compared with those who received whole blood. The fourth specific aim was addressed 
through a secondary analysis of the Inflammation and Host Response to Injury Trauma-
Related Data Base, to evaluate the relationship between volume and ratio of BCs 
transfused and development of ICs in patients with major trauma. Findings revealed that 
total transfused volume of PRBCs, injury severity, and comorbidities were associated 
with development of ICs. There were no differences in time to complication between 
PRBCs:FFP or PRBCs:PLTs ratio groups. 
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CHAPTER ONE 
Introduction 
 Trauma affects people of all ages, and remains one of the top five leading causes 
of death in the United States.(1) Uncontrolled hemorrhage is a major cause of death, and 
is preventable in many situations.(2) The standard of treatment for patients with trauma 
who experience exsanguination includes infusion of crystalloid fluid and either whole 
blood or blood components (packed red blood cells [PRBCs], fresh frozen plasma [FFP], 
and platelets [PLTs]). Due to economic and logistic reasons, transfusion of a combination 
of blood components rather than whole blood transfusion is the clinical standard of care 
for patients with trauma in the civilian setting.(3) According to the National Blood 
Collection and Utilization Report of 2011, 10% of PRBCs and 4% of PLTs were used by 
emergency and trauma services in United States hospitals.(4) However, less than 1% of 
all transfusions across the United States were whole blood transfusions, highlighting the 
lack of whole blood transfusions in the civilian setting.(4)  
 Transfusion is associated with trauma outcomes indirectly and directly.(5, 6) 
Indirectly, the volume of blood transfused, and the ratio of blood components are a proxy 
measure of injury severity; patients with more severe injury typically require more blood 
volume, and blood components to replace circulatory volume and factors necessary for 
coagulation.(7) Directly, transfusion is associated with morbidity and mortality by a 
number of mechanisms associated with the storage lesion, a combination of biological, 
chemical, and morphological changes in preserved blood components. Broad 
consequences of the storage lesion in transfused patients include vasoconstriction, 
systemic inflammation, acidosis, electrolyte imbalances, and decreased tissue 
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oxygenation.(8-11) The effects of the storage lesion only worsen over time; thus, patients 
after trauma who receive older stored components, especially in large volume, may 
experience increased risk of morbidity and mortality.  
 Consequences of the storage lesion were not recognized until the 1980s, and since 
that time there has been an ever-growing interest in the subject. Half of all studies 
published about the PRBC storage lesion were published either during or after 2009.(12) 
A plethora of evidence exists about mechanisms that produce the cellular morphology 
and breakdown that occurs with the storage lesion.(13-17) However, the association 
between the storage lesion and subsequent outcomes has not been fully explored. Recent 
data provided evidence to support an association between blood volume, ratio of 
components transfused and increased risk of complications and mortality.(18-22) As a 
result, current component transfusion practice for all patients is under scrutiny.(17, 23)  
 In recent years, investigators have initiated studies to test transfusion of fresh 
whole blood in patients after trauma to reduce morbidity and mortality that resulted from 
the storage lesion.(23) These studies were spurred by a growing body of evidence that 
suggested transfusion of blood components in a 1:1:1 fashion, or 1 unit of PRBCs to 1 
unit of FFP to 1 unit of PLTs, was beneficial for survival in trauma patients receiving 
massive transfusion (> 10 units PRBCs in 24 hours).(24-26) The rationale for the 
potential survival benefit was that this combination of transfused components closely 
mimicked whole blood. However, researchers contended that this benefit may not exist in 
patients who do not require large volume transfusion.(27)  
 Thus, trauma patients are exposed to increased risk of complications and mortality 
when transfused with stored blood components,(28, 29) and evidence to support current 
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transfusion strategies is lacking. Furthermore, limited research exists which evaluated the 
relationship between component storage lesion and both short-term and long-term patient 
outcomes after trauma. Therefore, the purpose of this dissertation was to evaluate the 
relationship between current trauma transfusion practices and associated outcomes in 
patients transfused after trauma. 
 Though the mechanisms of the storage lesion are described in the literature, the 
relationship between the storage lesion and patient outcomes following trauma and 
transfusion have not been elucidated. Chapter Two is a paper that presents a conceptual 
model developed from the current state of the science; the model describes the 
association of traumatic injury, hemorrhage, and blood component transfusion with short 
and long term outcomes. In this model, patient outcomes for each of the three 
components of trauma physiology and management (injury, hemorrhage, and transfusion) 
are separated into those occurring in the short-term (within 30 days), and those in the 
long-term (beyond 30 days). Specific emphasis was placed on the consequences of the 
storage lesion found in erythrocytes and platelets, the combined effects of biological and 
chemical breakdown that occurs with storage, and the evidence about outcomes 
associated with the storage lesion. 
 As the storage lesion impacts each stored unit of erythrocytes and platelets, 
outcomes for patients who are massively transfused must be considered. Chapter Three 
contains a systematic review of the literature focused on retrospective, observational 
investigations performed in civilian and military level I trauma centers, in which 
outcomes of patients who required massive transfusion after trauma were compared 
based on the ratio of components transfused. Based on the findings of this systematic 
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review, transfusion of components in a 1:1:1 ratio demonstrated a significant survival 
benefit for those patients who required massive transfusion after trauma. However, 
evidence about the association of transfusion ratio with clinical outcomes (e.g. hospital 
length of stay or rates of organ failure) was inconclusive.  
 Chapter Four reported the findings of a secondary analysis of the 2009 National 
Trauma Data Bank data set. The purpose of this study was to evaluate the relationship 
between transfusion type (whole blood versus components) and mortality risk in adult 
patients after major trauma. In this analysis, the type of transfusion was an independent 
predictor of mortality. Those patients who received components demonstrated a 3-fold 
risk of mortality likelihood compared with those who received whole blood. This finding 
is intriguing, though, as transfusion of whole blood in the civilian clinical setting is rare, 
whereas component transfusion is the standard of care for resuscitation. 
 Chapter Five reported a secondary analysis of the Inflammation and Host 
Response to Injury database. The purposes of this analysis were to evaluate: 1) the 
prevalence of inflammatory complications in blunt trauma patients who received blood 
transfusions, 2) the relationship between transfusion variables (volume and ratio of 
components) and the likelihood of an inflammatory complication (e.g. organ failure, 
pneumonia, septicemia), and 3) the relationship between transfusion variables and time to 
development of inflammatory complication in adult patients after major trauma. 
Inflammatory complications included organ failure, septicemia, catheter-related 
bloodstream infections, urinary tract infections, pneumonia, acute respiratory distress 
syndrome, and nosocomial infections. Patients included in the analysis received all three 
components (PRBCs, FFP, and PLTs). The ratios of both PRBC:FFP and PRBC:PLT 
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were calculated and presented in decimal notation (instead of 3:4, recorded as 0.75 or 
0.8). Total transfused volume was converted to units based on average volume of each 
component. 
Findings from this analysis revealed that the vast majority of patients (86%) developed at 
least one inflammatory complication. Results from a logistic regression determined that 
the presence of comorbidities and total transfused volume of PRBCs in the first 24 hours 
of hospitalization were independent predictors of inflammatory complications. There 
were no significant findings with other transfusion variables. Cox proportional hazard 
model analysis revealed the total transfused volume of PRBCs and injury severity were 
independent predictors of time to development of inflammatory complications. There 
were no differences in time to complications for PRBC:FFP or PRBC:PLT ratio groups.  
 Chapter Six concludes with an overall summary of findings from the manuscripts 
in the dissertation and the conclusions developed from these. In this chapter, I present 
future directions for research and implications for nursing care in this large and important 
patient population. 
 
 
 
 
 
 
 
Copyright © Allison Roenker Jones 2015 
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CHAPTER TWO 
Consequences of Blood Component Transfusion in Patients with Trauma:  
A Conceptual Model 
 
Synopsis 
 Blood component transfusion is frequently required in resuscitation of patients 
with major trauma. Packed red blood cells and platelets experience breakdown and 
chemical changes during storage (known as the storage lesion) that lead to an 
inflammatory response once transfused to patients. The pathophysiology associated with 
the storage lesion, and the relationship between the storage lesion and outcomes of 
transfused trauma patients are discussed. Outcomes related to trauma, hemorrhage, and 
component transfusion are presented in a conceptual model, grouped according to those 
occurring in the short-term (≤ 30 days) and the long-term (> 30 days). 
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Introduction 
 Unintentional injury remains one of the leading causes of death for people of all 
ages in the United States.(1) The most common cause of death for trauma patients within 
the first 48 hours of injury is exsanguination, accounting for 30-40% of traumatic 
deaths.(2) Such bleeding, or massive hemorrhage, is defined as either: 1) the loss of 
blood equal to the circulating volume of the patient within 24 hours; or 2) the loss of half 
of the circulating volume within three hours.(3) Management of hemorrhage includes 
fluid replacement and/or transfusion of whole blood or blood components, which include 
packed red blood cells (PRBCs), fresh frozen plasma (FFP) and platelets (PLTs).  
 The physiological and clinical consequences of traumatic injury, subsequent 
hemorrhage, and transfusion include those that occur within 30 days of injury, or short-
term, and those occurring beyond the initial 30-day timeframe, or long-term. Short-term 
consequences of injury, hemorrhage, and subsequent blood transfusion, primarily 
mortality and major complications during hospitalization, have been described in the 
trauma literature, especially among trauma patients who received massive transfusion.(4-
7) Long-term physiological and psychological consequences of traumatic injury have also 
been the subject of a multitude of research studies, ranging from rehabilitation 
(physiological) to post-traumatic stress disorder and depression (psychological) related to 
major traumatic injury.(8-12) However, the mechanisms connecting trauma, hemorrhage, 
and transfusion with short- and long-term outcomes have not been thoroughly 
synthesized. 
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Blood Transfusion and Potential Consequences 
 Approximately 1-3% of trauma patients require transfusion of blood components 
to stabilize their hemodynamic state.(13) In addition, 2% of these patients will require 
massive transfusion of blood products (10 units or more of PRBCs in a 24 hour 
period).(3, 14) Transfusion of blood components, in combination with the immediate 
effects of the trauma, often has multiple detrimental effects for the recipients, resulting in 
increased risk of morbidity and mortality.  
 Marik and Corwin (15) performed a systematic review of 45 observational studies 
of critically ill patients, 10 of which included trauma patients. Using pooled data from 
these studies, they found PRBC transfusion independently predicted nosocomial 
infection, with nearly double the likelihood of infection compared to those not transfused 
(Odds ratio [OR] 1.8, 95% CI 1.5 – 2.2). Additionally, these investigators found that 
PRBC transfusion independently predicted mortality (OR 1.7, 95% CI 1.4 – 1.9), and 
development of acute respiratory distress syndrome (OR 2.5, 95% CI 1.6 – 3.3). Other 
investigators have found similar associations between transfusion of PRBCs and adverse 
clinical outcomes, such as transfusion-related acute lung injury,(16, 17) acute kidney 
injury,(18) and thromboembolic events.(19) 
 Current blood bank practices include rotation of PRBCs near their expiration date 
to trauma centers more likely to use them before expiration, thus reducing waste.(20) 
However, predictable and identifiable morphological, biochemical, and functional 
alterations occur in blood components, known collectively as the storage lesion, which 
are associated with physiological consequences in those receiving the transfusion (Tables 
1).(21, 22) While evidence exists to support associations between patients who received 
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blood transfusions after trauma and physiological consequences, the underlying 
pathophysiological mechanisms connecting blood transfusions with these outcomes 
remain unclear; investigators suggested that these outcomes may be the result of the 
inflammatory response initiated by transfusion.(23) Thus, the purpose of this paper is to: 
1) discuss the relationship between the elements of the storage lesion and consequences 
of blood transfusions in trauma patients; and 2) to present a conceptual model of the 
short- and long-term consequences of trauma, hemorrhage, and blood transfusion in this 
population. 
Pathophysiology of Trauma 
 Traumatic injuries are categorized as blunt or penetrating depending on the 
mechanism of the insult. Penetrating injuries (i.e. stabbing or gunshot wound), are 
typically fairly isolated injuries specific to the tissues in the path of the instrument or 
projectile; these injuries tend to have more severe physiological impact, associated with a 
five-fold increase in mortality likelihood (OR 5.4, 95% CI 2.4-12.0, p < 0.01).(24) 
Patients with penetrating injuries have a higher likelihood of requiring blood transfusion, 
particularly massive transfusion.(25-27) In contrast, blunt injuries (i.e. motor vehicle 
accidents) result in more broadly distributed damage. No matter the mechanism, 
endothelial disruption and blood loss stimulate a coagulation cascade with the intent of 
reduction in hemorrhage. In addition, blood is shunted to the brain, heart, and lungs to 
ensure survival.  
 Inflammatory cytokines (i.e. interleukin-6 and tumor necrosis factor-alpha) 
stimulate the recruitment of white blood cells to the site of injury, and initiate a 3-phase 
response that consists of acute inflammation, repair, and remodeling. Vasoconstriction 
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occurs immediately after injury to restrict blood loss; this response transitions to 
vasodilation with increased vascular permeability to increase perfusion, remove foreign 
bodies, and deliver inflammatory and repair molecules. Vasodilation produces edema, 
erythema, and in conjunction with release of histamine, bradykinin, and serotonin, causes 
acute pain.  
 The initial vasoconstriction after trauma results not only from the injury itself, but 
also from what is known as the lethal triad, a combination of hypothermia, acidosis, and 
coagulopathy commonly associated with trauma. Investigators of an 8-year study 
reported no survivors among those patients who presented to the emergency department 
with the lethal triad.(28) Thus, understanding the combined effects of the 
pathophysiology of traumatic injury and the lethal triad is critical to caring for this 
population. 
Hypothermia 
  Nearly one fifth of traumatic injuries (18%) occurred outside of the home,(29) 
with trauma patients exposed to the elements for an indefinite period of time; 
hypothermia may result. Investigators estimated that 13% of trauma patients presented 
with an admission temperature less than 35°C (95°F),(30) while less than 1.6% had an 
admission temperature of less than 32°C (89.6°F).(31) Core temperature below 37°C 
(98.6°F) alter the hemoglobin molecule structure, and produce an increased affinity for 
oxygen,(32) which results in less oxygen released at the metabolically active cell, and 
subsequent cellular hypoxia.(32) Persistent hypothermia can result in alterations in 
cardiac conduction, decreased respiratory rate, and reduced myocardial contractility.(33) 
Furthermore, investigators found hypothermia independently predicted mortality in 
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trauma patients, with an increased likelihood of death of nearly 20% (OR 1.19, 95% CI 
1.05 – 1.35, p = 0.008).(34) While hypothermia alone may affect the status and outcome 
of the patient, it is rarely independent of other complications in patients with trauma.   
Acidosis 
 In patients after trauma, clinicians generally attributed acidosis to the production 
of lactic acid, a metabolite of energy production mechanisms, glycolysis and oxidative 
phosphorylation.(35)  However, trauma can increase the rate of glycolysis to 2 to 3 times 
more than oxidative phosphorylation due to physiological stress, which results in rapid 
production of lactate, and subsequent systemic acidosis. In the period immediately 
following injury, acidosis contributes to development of coagulopathy. Cosgriff and 
colleagues (36) compared patients who developed coagulopathy with those who did not, 
and found that a significantly greater proportion of those who developed coagulopathy 
had a pH < 7.1 compared to those who did not develop coagulopathy (78% vs 32%, p = 
0.0004). At a pH below 7.1, patients experienced reduced platelet count and platelet 
dysfunction, increased fibrinogen breakdown, and impaired plasma protease 
function.(35) Consequences of persistent acidosis extended beyond the resuscitation 
period and included decreased cardiac contractility, and reduced renal perfusion.(33) For 
patients who experienced continued increased lactate levels after traumatic injury, 
unresolved hemorrhage was the primary suspected mechanism.(33) Investigators 
examined the association between acidosis and coagulopathy, and found that at a pH of 
6.8, thrombus formation time increased by more than 160% compared to thrombus 
formation times measured at a pH of 7.4.(37) Thus, the pH level and coagulopathic state 
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directly impact each other, and if unresolved, produce deadly outcomes in patients with 
trauma.  
Coagulopathy  
 Following activation of the coagulation cascade, patients experience an increase 
in fibrinolytic activity, and plasminogen activation to balance the degree of 
coagulation.(38) Patients who experienced widespread tissue damage also developed a 
systemic coagulation response due to thrombin release.(38, 39) Infusion of crystalloids 
and blood components during resuscitation may result in a dilutional coagulopathy, 
especially those patients who received massive transfusion (10 or more units of PRBCs in 
24 hours). Unfortunately, coagulopathy after trauma was associated with a 35% increase 
in likelihood of mortality (Figure 2.).(40) Hypothermia, which is closely associated with 
coagulopathy, also decreased platelet function.(33) Hypothermia associated with 
coagulopathy occurs when core temperature was below 33°C (91.4°F).(39) Dirkmann 
and colleagues (41) reported significant increase in thrombus formation time 
(approximately 145 seconds) at a pH of 7.26 ± 0.04 with concommitant hypothermia 
(33°C or 91.4°F), compared to a control (approximately 115 seconds at 36°C or 96.8°F 
and pH of 7.36, p < 0.05) which highlights the interplay of the lethal triad. Investigators 
concluded that for patients with devastating injury, this combination required aggressive 
resuscitation measures to correct coagulopathy and stop ongoing hemorrhage.(35, 42)  
Assessment of coagulation 
Standard measures of coagulation include prothrombin time (PT), activated partial 
thromboplastin time (aPTT), and the International Normalized Ratio (INR). While these 
measures reflect the ability to coagulate and initiate hemostasis, the logistics of 
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measurement require a prolonged waiting period for results (typically around 30 minutes 
or more), which can delay treatment. Patients after trauma present a unique challenge in 
the immediacy of their coagulation needs; therefore, clinicians and researchers have 
begun using thromboelastography to guide resuscitation.  
Thromboelastography (TEG) is a measure of the viscoelastic changes that occur during 
coagulation and lysis of whole blood (Table 2, Figure 3.).(38, 43) TEG measures the time 
for thrombus generation, the strength of the thrombus, as well as lysis of the 
thrombus.(43, 44) Investigators found strong correlations between TEG values and 
traditional coagulation values in patients after trauma (e.g. PT, aPTT), which provided 
evidence to support the use of TEG for resuscitation.(45)  TEG results are completed 
within 20 minutes, which provides clinicians with data upon which to base 
resuscitation.(45, 46) The primary drawbacks to TEG are the cost of the testing, and the 
time required (approximately two days) for personnel training in TEG use and 
interpretation.(46, 47) Overall, evidence to support the use of TEG in the trauma setting 
as a guide for resuscitation continues to grow.(48-50) 
Historical Perspective of Transfusion  
 Transfusion originally involved transfusion of whole blood. With World War II, 
the United States military found it necessary to preserve and send blood to the front lines 
for resuscitation of injured soldiers.(51) Thus, scientists developed procedures to preserve 
blood components like albumin and plasma proteins for transfusion. In the 1950s, the 
development of the cell separator led to the transfusion of blood components like packed 
red blood cells and fresh frozen plasma, which currently remains the standard in civilian 
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practice. Discussion of transfusion of stored components necessitates understanding of 
the associated storage lesion.  
The Storage Lesion of Cellular Components 
 Changes associated with the storage lesion include: 1) cellular and morphological 
changes, 2) oxygenation and energy changes, 3) biochemical changes, 4) release of 
microparticles, and 5) increase in inflammatory mediators. The storage lesion develops in 
a predictable fashion over time, such that the longer the component is stored, to the 
greater degree of disruption to cellular integrity is detected (Table 3).  
Packed Red Blood Cells 
Cellular and Morphological Changes 
 During storage, PRBCs experience cell shape and membrane integrity alterations, 
with change from the normal smooth, flexible disc to spherical cells with sharp 
protrusions, called spheroechinocytes.(52, 53) Karon and colleagues (54) found that these 
morphological changes occurred rapidly, and early in the storage period, with 9.5% of 
cells deemed abnormal (i.e. spheroechinocytes) by day seven of storage. Due to their new 
shape and lack of flexibility, spheroechinocytes are unable to pass through the 
microvasculature, because the protrusions are more likely to cause the cells to adhere to 
the endothelium.(55, 56) Anniss and Sparrow (57) found that the number of adherent red 
blood cells increased significantly from 69 ± 10 cells per mm2 on the first day of storage 
to 128 ± 11 cells per mm2 on storage day 42 (p < 0.05).(57) Consequently, transfused 
PRBCs have significantly reduced flow through the microcirculation, with less oxygen 
delivered to metabolically active cells; these abnormal erythrocytes also obstruct the 
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microcirculation, and may result in cellular ischemia, and tissue and organ 
dysfunction.(55, 58)  
Oxygenation and Energy Changes 
 During storage, biochemical changes result in a reduction in 2,3-
diphosphoglycerate (2,3-DPG), a byproduct of glycolysis in the red blood cell.(21) A 
reduction in 2,3-DPG produces a left shift of the oxyhemoglobin dissociation curve; thus, 
the beta chain of the hemoglobin molecule will have greater affinity for the oxygen 
molecule, and will not release oxygen at the cell. Almac and Ince reported that the 2,3-
DPG concentration fell below detectable levels within two weeks of preservation.(59) 
The increased oxygen affinity in transfused PRBCs will continue until the recipient 
produces adequate 2,3-DPG levels. However, 2,3-DPG levels in transfused patients 
return to normal within the first few days after transfusion.(60, 61) Stan and colleagues 
found that 2,3-DPG levels reached more than 60% of normal value (measured at 72 
hours) within 24 hours of transfusion completion.(60) However, for patients who 
received massive transfusion, replacement of their entire blood volume, lower levels of 
2,3-DPG transfused in large volumes of stored components may significantly reduce 
cellular oxygen concentration for several hours after transfusion completion.  
 Erythrocyte metabolism continues after initiation of the storage and preservation 
process, as the supernatant, or the fluid in which the cells are stored, contains glucose. In 
the absence of oxygen, erythrocytes convert to anaerobic metabolism of glucose to 
produce adenosine triphosphate, or ATP.(62) Investigators recently reported a 1 to 2-fold 
increase in ATP levels during the first two weeks of storage for PRBCs, with levels 
falling below their initial levels by the end of the 42-day storage period.(63) This initial 
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rise in ATP levels was attributed to release of ATP in response to a hypoxic state, where 
ATP acted as a vasodilator in vivo.(64) Krager and colleagues examined 40 units of 
leukocyte-depleted whole blood, and described a change in ATP levels from an average 
of 3.5 + 0.4 𝜇mol/g of hemoglobin (Hb) on day 1 to an average of 2.3 + 0.4 𝜇mol/g Hb 
on day 42.(65) With continued anaerobic metabolism and limited stores of glucose 
available, the finite amount of ATP found in the stored components gradually decreased 
during storage. ATP depletion was associated with cellular alterations, as the ATP pump 
within the cell membrane failed, and resulted in sodium accumulation within the cell; this 
lead to stiffened cellular structure due to swelling, and loss of phospholipid membrane 
through formation of microvesicles (small pieces of the membrane that break off).(66) 
The combination of altered cellular chemistry and structure resulted in decreased 
oxygenation ability through increased oxygen affinity and inability to travel through 
microvasculature. Extended tissue oxygen deprivation may result in organ damage and/or 
dysfunction, especially to those tissues most sensitive to hypoxia, myocardial and 
cerebral tissues, for example.(67) 
Biochemical Changes 
 Anaerobic metabolism results in by-products, that include lactic acid, and excess 
hydrogen ions from breakdown of fatty acids for additional energy, both ultimately lead 
to a reduced intracellular pH level following persistent hypoxia.(67) With decreased ATP 
available for essential functions, like the sodium-potassium pump, cells accumulate 
sodium as the pump fails; this results in cellular edema, weakening of the cell membrane, 
and cellular internal structures, such as the mitochondria.(67) Extracellular potassium 
concentrations also increase with failure of the sodium-potassium pump. Investigators 
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found significant increases in plasma potassium levels during storage, from 5.16 ± 1.2 
mmol/l on day 0 to 35.1 ± 4.6 mmol/l on day 28 (p < 0.005).(68) Two developments 
characterize irreversible cellular damage, cessation of mitochondrial function, and the 
loss of membrane function.(67) Irreversible damage such as this occurs in approximately 
50% of PRBCs by day 21 of storage.(53) Once transfused, damaged red blood cells may 
succumb to apoptosis, or be removed from the circulation similar to normal processing of 
old red blood cells, thereby decreasing the overall effectiveness of the transfused unit. 
Release of Microparticles  
 After the cell membrane is no longer intact, intracellular fluid and cellular 
contents leak into the extracellular space. Several substances escape from cells with 
cellular structure breakdown; these include microvesicles containing plasma membrane 
components, lipids, free hemoglobin, free iron, and cytokines. Chaudhary and Katharia 
(68) found a significant increase in plasma hemoglobin during storage (day 0 0.017 ± 
0.01 g/dL, day 28 0.077 ± 0.06 g/dL, p < 0.005). Release of microvesicles is associated 
with decreased endothelial-derived nitric oxide, which is a potent vasodilator and 
antioxidant,(52) and induction of a hypercoagulable state.(69) Free hemoglobin and free 
iron contributed to oxidative stress in the cells, with subsequent free radical production, 
which may initiate tissue damage once transfused.(52) Longer storage time is associated 
with greater release of microvesicles.(69) Thus, given that trauma centers receive older 
stored PRBCs, the concentration of microvesicles is likely substantively elevated.  
Increase in Inflammatory Mediators  
 The storage lesion is also associated with an increased release of inflammatory 
mediators. Kor and colleagues (58) found cytokine and other proinflammatory mediator 
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concentrations rose throughout the duration of storage in 22 units of leukocyte-reduced 
PRBCs. Their findings suggested that despite the removal of white blood cells, some 
proinflammatory molecules remained in stored PRBCs. Ubiquitin, a protein found in all 
eukaryotic cells, related to inflammation through inhibition of tumor necrosis factor-
alpha, is also released with the breakdown of the cell membrane.(70, 71) Patel, Proctor 
and Majetschak (71) found a significant increase in ubiquitin levels during storage, 
ranging from 113 ± 33 ng/mL on day 0 to 2170 ± 268 ng/mL on day 42 (p < 0.001). 
Thus, through transfusion of PRBCs, patients experience an inflammatory reaction and 
subsequent adverse outcomes. 
Platelets 
Cellular and Morphological Changes 
 Although similarities exist between PRBC and PLT storage lesion effects, our 
current understanding about the PLT storage lesion lacks in comparison to that of 
PRBCs. Storage of PLTs stimulated a process that mimicked PLT activation in vivo,(72) 
which ultimately resulted in membrane breakdown and alteration of the cell shape, 
changing the cell from a smooth, plate-shaped structure to a rounded cell with spiny 
protrusions.(73) Through PLT activation, membrane breakdown, and exposure of 
phosphatidylserine (a phospholipid found on the inner portion of the platelet cell 
membrane), PLTs may develop procoagulant properties, whereby they become capable of 
thrombin generation, and premature cell death while in storage or soon after 
transfusion.(74) Investigators reported a minimal decrease in the efficacy of transfused 
PLTs, but determined that structurally altered PLTs are removed from circulation more 
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rapidly than non-altered PLTs, due to stimulation of the apoptosis cell death pathway via 
structural change.(73)  
 The most effective method of PLT storage remains controversial, with the 
primary challenge centered on the balance between maintenance of cellular integrity and 
reduction in risk of bacterial contamination. Current standards include storage of PLTs at 
room temperature with continuous agitation for 5 days.(73, 75) Previous standards, 
however, included refrigeration of PLTs during storage, which was intended to decrease 
likelihood of bacterial contamination.(73) Change in these standards was based on 
research findings that determined cold storage temperature was associated with premature 
PLT removal from the circulation via the liver; thus, cold storage reduced PLT 
circulation time.(76) Researchers evaluated PLTs stored at 4°C (39.2°F) for at least 48 
hours prior to transfusion in mice, and found that approximately 50% of the transfused 
PLTs were cleared from circulation within 2 hours.(77) Recently, investigators suggested 
that refrigerated PLTs might be more beneficial to trauma patients, as they are somewhat 
activated prior to transfusion, and therefore contributed to hemostasis more rapidly.(76) 
Thus, while PLTs experienced morphological changes and activation during storage, they 
remained effective, albeit for a shorter period of time. 
Oxygenation and Energy Changes 
 Like PRBCs, anaerobic metabolism during PLT storage often leads to depletion 
of ATP, and consequently, breakdown of the plasma membrane and leak of the 
intracellular contents into the extracellular fluid.(74) Investigators described a statistically 
significant loss of PLTs when ATP levels fell below 2 𝜇ml/1011 PLTs (p < 0.001).(78) 
PLTs survived for a maximum of 9-10 days in vivo before apoptotic cell death 
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(programmed death). However, an alternative form of cell death may occur. Investigators 
suggested that stored PLTs experienced increased necrotic cell death, which was 
associated with ATP depletion during storage. Necrotic cell death included destruction of 
the plasma membrane, and edema of the cell and cell organelles, which subsequently lead 
to cell lysis.(74) No matter the cause of cell death during storage, the result is the same, 
breakdown of the cell, and activation of a procoagulant state. 
Biochemical Changes 
 PLT necrosis during storage resulted from initiation of one of many death 
activation pathways (e.g. hypoxia), each culminated with the cessation of mitochondrial 
function and ATP depletion.(74) A major consequence of this, the increased production 
of reactive oxygen species, is associated with the destruction of organelles, the plasma 
membrane, and ultimately the cytoskeleton.(74) PLTs also reverted to anaerobic 
metabolism in the absence of glucose, with subsequent accumulation of lactic acid, 
hydrogen ions, and consequent decreased pH. Depletion of ATP also resulted in failure of 
ATP-dependent processes, which led to electrolyte imbalances in PLTs similar to those in 
PRBCs.(74) Thus, multiple sources of cellular injury are described during PLT storage. 
Release of Microparticles 
 PLT activation includes expression of membrane receptors, which triggered 
release of microparticles.(79) Investigators suggested that these microparticles have 
procoagulant properties, which makes them beneficial to recipients, but may also 
stimulate an immune response.(79) In addition, PLTs contain three types of granules with 
proinflammatory properties; these include alpha granules (primarily proteins, i.e. P-
selectin), dense granules (contain small molecules, i.e. serotonin or ATP), and lysosomal 
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granules (contain degradative enzymes).(79) The mechanisms by which microparticles 
trigger inflammation have yet to be fully elucidated. 
Increase in Inflammatory Mediators 
 Storage may stimulate PLT activation, which resulted in necrotic cell death; these 
effects worsen over storage time. PLT activation also triggered development and release 
of inflammatory mediators (thromboxane and prostaglandins), which stimulated an 
inflammatory response in the recipient.(79) Investigators also suggested that transfusion 
of PLTs after necrotic cell death exacerbated recipient inflammation.(74) Furthermore, 
PLT transfusion commonly stimulated inflammation, with receipt of “foreign” PLTs 
from a donor.(79) Inaba and colleagues reported that trauma patients who received 
apheresis PLTs stored for 4 days and 5 days were approximately 20% more likely to 
experience development of complications when compared with those who received 
apheresis PLTs stored ≤ 3 days (p < 0.001).(80) However, investigators currently lack a 
full understanding of the mechanisms responsible for this relationship. 
Short-term and Long-term Consequences of Stored Component Transfusion 
Reperfusion Injury 
 One of the more immediate consequences of transfusion of stored blood 
components is reperfusion injury. Reperfusion injury occurs when tissues deprived of 
adequate circulation subsequently receive oxygen and nutrients with restored circulation. 
In highly oxygen-dependent tissues such as the brain, damage can occur after mere 
seconds or minutes of oxygen deprivation.(81) Under normal circumstances, the body 
both produces and sufficiently processes reactive oxygen species (ROS) with the use of 
antioxidants available to the tissues. With reperfusion injury, when oxygen is restored to 
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hypoxic tissues, the result is an over-production of ROS that the body is ill-equipped to 
manage due to a limited supply of antioxidants.(81) In addition, nitric oxide (a 
vasodilator produced by endothelial cells in normal conditions, but produced by smooth 
muscle cells in a state of hypoxia) levels decreased, as the cells are now provided with 
adequate oxygen and circulation is restored.(82)  
Once released from the mitochondria, these ROS cause additional irreversible 
cellular damage in addition to the initial hypoxic insult.(81) When reperfusion injury 
occurs, it stimulates an inflammatory response, where neutrophils are recruited to the site 
of injury.(83) In recent years, the focus of reperfusion injury and its associated outcomes 
has included areas such as cardiac arrest and resuscitation, hypoxic-ischemic brain injury, 
or stroke.(81) Kunimatsu and colleagues (84) reported that ROS development was 
greatest in the first 15 minutes following reperfusion in patients with “global brain 
ischemia”. In spite of our current understanding about reperfusion injury, little research 
exists about the consequences of reperfusion injury after trauma and subsequent 
transfusion.  
Vasoconstriction 
  Traumatic injury induces vasoconstriction to shunt blood to vital organs, and 
reduce blood loss at the site of injury. Furthermore, traumatic injury associated with 
environmental exposure induces vasoconstriction to preserve body heat. To restore blood 
volume, blood or blood components and intravenous fluids infusion is the current 
standard for resuscitation. Blood and fluid warmers increase the temperature of infused 
fluids; however, these warmers may not increase the temperature of infused fluids to that 
of body temperature. Thus, patients hypothermic due to exposure are infused with cold or 
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cool fluids in typically large volumes, which further stimulates vasoconstriction, and 
subsequent reduction of circulation to metabolically active tissues. In addition, patients 
after trauma are likely to receive older stored blood components with greater acidity, 
which will exacerbate vasoconstriction.   
Inflammation 
 One of the consequences of the storage lesion is morphological alteration of the 
shape of both PRBCs and PLTs, and the release of microparticles (MPs) from these cells; 
these MPs stimulate an inflammatory response. PLTs play a significant role in the 
immune response, thus transfusion of PLTs with foreign antibodies also generates an 
inflammatory response.(79) Such response can lead to a transfusion-related reaction; 
signs normally associated with such reactions (i.e. fever, rash, erythema) occur within 
minutes of transfusion. In fact, PLT transfusions induced approximately three times more 
adverse effects than PRBC transfusions; PLT-associated adverse events occurred in one 
out of every 1,030 PLT transfusions.(85)  
MPs consist of small pieces of plasma membrane expelled by cells of all types 
when stimulated by a stressor or trigger (e.g. initiation of cell death pathways); once the 
trigger initiates this process, the number of microparticles released only increased.(86) 
Microparticles are shed from cells on a regular basis, and are capable of expression of 
surface markers of their cell origin.(86) In other words, these MPs released from PLTs 
are able to impact inflammatory reactions, among other cellular activities, just as PLTs 
do.(86, 87) Investigators suggested that microparticles from PLTs suppressed immune 
response after transfusion; thus further contributing to the development of 
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complications.(88) The extent of the relationship between microparticles and clinical 
complications after transfusion has yet to be fully elucidated. 
Impaired immune reaction 
 The consequences of traumatic injury and resuscitation include hypothermia, 
acidosis, and decreased metabolic activity, with greater energy expenditure. Initially, an 
inflammatory response is stimulated; however, after this initial response there is initiation 
of an anti-inflammatory state as healing begins.(83) Xiao and colleagues investigated 
leukocyte gene expression in patients after trauma, measured immediately following 
injury, first within 12 hours of injury, then on days 1, 4, 7, 14, 21, and 28.(89) They 
found that patients with severe trauma experienced a change in more than 80% of the 
leukocyte gene expression within 28 days of injury. In addition, the most notable change 
in gene expression occurred within the first 12 hours following injury. Of the genes in 
which expression increased the most, 80% were involved with inflammation or innate 
immunity; of those that were notably inhibited, 90% were associated with antigen 
presentation and activation of T cells. The investigators also reported that over 50% of 
the genes examined had not returned to normal after 28 days. In some cases, these 
continued anti-inflammatory responses, when combined with endothelial damage and 
other factors such as comorbidities, lead to complications like acute respiratory distress 
syndrome or multiple organ failure.(83) Consequently, patients experienced an increased 
possibility of infection via open wound, through invasive procedure, or development of 
inflammatory complications during hospitalization. The prolonged effects of this 
impaired immune reaction remain unknown. 
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Clinical complications 
 In a recent meta-analysis, investigators evaluated studies comparing outcomes of 
patients based on transfusion of aged stored blood, defined as anywhere from 9 to 42 
days in storage.(90) They found that in seven of 21 studies, receipt of older PRBC 
transfusions was associated with development of complications during hospitalization, 
that included pneumonia, deep vein thrombosis, acute respiratory distress syndrome, 
multiple organ dysfunction syndrome, renal failure, sepsis, acute renal failure, and sepsis. 
The overall estimate of increased risk included increase in risk of multiple organ 
dysfunction syndrome (OR 2.26, 95% CI 1.56-3.25) and pneumonia (OR 1.17, 95% CI 
1.08-1.27). The relationship between blood component transfusion and complications, 
and the mechanisms by which the storage lesion affects these outcomes remains unclear. 
However, evidence such as that presented here suggested that detrimental effects are 
associated with transfusion of older components. With current blood bank practices, older 
units of blood components are sent to trauma centers; thus, patients transfused following 
major trauma may experience a greater risk of complications. Few investigators have 
examined long-term effects of transfusion. Possibilities for future research of such 
outcomes include, but are not limited to chronic organ dysfunction, cognitive 
dysfunction, physical or mental disability, awareness of disability, hospital readmission, 
rehabilitation requirements, and return to baseline status.  
Evidence-Based Conceptual Model 
 Consequences of physical trauma and hemorrhage have been thoroughly 
examined in the healthcare literature. Currently, knowledge about transfusion after 
trauma and the storage lesion focuses primarily on short-term, clinical complications 
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likely to develop during hospitalization. For those patients who survive past their 
hospitalization, however, there is a lack of knowledge and evidence about the potential 
long-term consequences of the storage lesion and transfusion following traumatic injury. 
Thus, the conceptual model presented here (Figure 1.) was developed as a representation 
of the current state of knowledge about the relationship between traumatic injury, 
hemorrhage, and transfusion of blood components with both short- and long-term 
consequences. Areas on the top half of the model denote short-term consequences, and 
those on the bottom denote the long-term consequences. As indicated by the area at the 
bottom, right-hand corner of the figure, the opportunities for exploration of long-term 
transfusion consequences are essentially unlimited and untouched.  
Conclusion 
 Trauma affects a significant portion of the population annually, with severely 
injured patients in need of transfusion of blood components and fluid for resuscitation. 
Current standards of blood component preservation support extended storage periods, 
which are associated with deleterious effects on the cells, the storage lesion. The short- 
and long-term consequences of trauma and short-term consequences of hemorrhage have 
been well described; further research is required to determine the extent of long-term 
consequences of hemorrhage, paired with the consequences of stored component 
transfusion. 
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Table 2.1a Global Consequences of the Storage Lesion for Packed Red Blood Cells 
 
Storage Lesion 
Alterations 
Storage Lesion Effects  Physiological Consequences After 
Transfusion 
Cellular and 
Morphological 
Changes 
• Irreversible change 
from smooth, easily 
deformable discs to 
spheroechinocytes (less 
flexible, spherical cells 
with protrusions) 
• Development of 
microvesicles with 
procoagulant properties 
• Difficulty moving through 
smaller blood vessels 
• Unable to oxygenate tissues 
adequately 
• Reperfusion injury due to 
release of free radicals 
• Inflammation due to 
spheroechinocytes adhering 
blood vessels 
Oxygenation and 
Energy Changes 
• Reduction in 2,3-DPG 
• Impaired ability to 
carry/deliver oxygen 
• Decrease in ATP  
• Left shift in oxyhemoglobin 
dissociation curve  
• Impaired circulation and 
inadequate tissue oxygenation 
• Failure of ATP pump; cellular 
swelling 
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Table 2.1a, Cont. 
 
Biochemical Changes • Decrease in ATP 
• Switch from aerobic 
metabolism to 
anaerobic metabolism 
• Failure of ATP pump; 
electrolyte imbalance of 
transfused supernatant 
(increased potassium); increased 
lactate 
• Excess hydrogen ions, build up 
of lactic acid, decrease in pH 
• Irreversible cellular damage 
Release of 
Microparticles 
• Breakdown of 
phospholipid 
membrane; 
microparticles released 
into supernatant 
• Increase in free hemoglobin, free 
iron, cytokines, plasma 
membrane 
• Vasoconstriction; induction of 
hypercoagulable state, tissue 
damage, and inflammation 
Increase in 
Inflammatory 
Mediators 
• Due to breakdown of 
cellular structure and 
leaking of cellular 
contents 
• Increase in ubiquitin and 
cytokine levels throughout 
storage 
• Induction of inflammatory 
reaction 
2,3-DPG  = 2,3-diphosphoglycerate; ATP = adenosinetriphosphate 
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Table 2.1b Global Consequences of the Storage Lesion for Platelets 
 
Storage Lesion 
Alterations 
Storage Lesion Effects  Physiological Consequences 
After Transfusion 
Cellular and 
Morphological 
Changes 
• Irreversible change 
from smooth, easily 
deformable plate-
shaped cells to 
spheroechinocytes (less 
flexible, spherical cells 
with protrusions) 
• Platelet activation 
• Development of 
microvesicles  
• Difficulty moving through 
smaller blood vessels 
• Membrane breakdown; 
exposure of phosphatidylserine; 
potentially early cell death 
• Development of procoagulant 
properties 
 
Oxygenation and 
Energy Changes 
• Switch from aerobic 
metabolism to 
anaerobic metabolism 
• Decrease in ATP 
• Breakdown of plasma 
membrane, leaking of 
intracellular contents 
• Potential cellular death due to 
membrane breakdown 
• Build up of lactic acid, excess 
hydrogen ions, drop in pH 
Biochemical Changes • Decrease in ATP • Failure of ATP pump; 
electrolyte imbalance; cellular 
swelling 
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Table 2.1b, Cont. 
 
Release of 
Microparticles 
• Expression of 
membrane receptors; 
phospholipid 
membrane breakdown 
• Release of microparticles with 
procoagulant and pro-
inflammatory properties 
Increase in 
Inflammatory 
Mediators 
• Platelet activation; 
breakdown in cellular 
structure 
 
• Development and release of 
inflammatory mediators 
 ATP = adenosinetriphosphate 
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Table 2.2 Thromboelastography Measures and Correlations to Traditional 
Coagulation Testing (44,45) 
 
TEG 
Value 
Measures Correlation to 
Traditional 
Coagulation 
Tests 
Normal 
Range 
Transfusion 
Recommendation 
P Value 
R 
time* 
Coagulation 
factors (time to 
initial fibrin 
formation) 
PT   
aPTT   
PLT 
5-10 min > 10 min: FFP, 
cryoprecipitate 
PT: < 
0.001 
aPTT: < 
0.001 
PLT: 
0.12 
K 
time** 
Fibrinogen, 
platelet number 
(time for 
thrombus to 
reach 20 mm 
thrombus 
strength)  
PT 
aPTT 
PLT  
1-3 min > 3 min: FFP, 
cryoprecipitate 
PT: < 
0.001 
aPTT: < 
0.001 
PLT: 
0.02 
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Table 2.2, Cont. 
 𝛼 angle Fibrinogen, 
platelet number 
(angle from 
baseline to 
slope of tracing 
– indicates 
thrombus  
formation) 
PT 
aPTT 
PLT 
53° – 72° < 53°: platelets 
with or without 
cryoprecipitate 
PT: < 
0.001 
aPTT: < 
0.001 
PLT: < 
0.001 
MA Platelet 
function 
(maximum 
amplitude of 
tracing) 
PT 
aPTT 
PLT 
50 – 70 
mm 
< 50 mm: platelets PT: < 
0.001 
aPTT: < 
0.001 
PLT: < 
0.001 
G 
value  
Coagulation 
cascade  
PT 
aPTT 
PLT 
5.3 – 12.4 
dynes/cm2 
N/A PT: 0.005 
aPTT: -
0.19 
PLT: 
0.03 
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Table 2.2, Cont. 
 
LY 30 †† Fibrinolysis (thrombus lysis 
at 30 minutes 
following MA) 
N/A 0-3% > 3%: tranexamic 
acid 
N/A 
 R time = Reaction time; K time = Kinetic time; MA = Maximum amplitude; G value = calculated value of 
clot strength; LY30 = clot lysis at 30 minutes;  PT = prothrombin time; aPTT = activated partial 
thromboplastin time;  PLT = platelet count 
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Table 2.3 Blood Component Storage (91)  
 
Component Storage 
Method 
Maximum 
Storage Time 
Preservatives Additives 
Packed red 
blood cells 
Refrigerated 42 days Anticoagulant – 
some 
combination of 
citrate, 
phosphate, 
dextrose, and/or 
adenine 
One of the 
following: 
Adsol®, 
Nutricel®, 
Optisol®, 
SOLX® 
Fresh frozen 
plasma 
Frozen 1 year; if 
thawed, must be 
used 
immediately 
Anticoagulant N/A 
Platelets Room 
temperature, 
with constant 
agitation 
5 days Anticoagulant 
(apheresis only) 
One of the 
following: 
InterSol®, 
Isoplate™ 
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Figure 2.2 Thromboelastography Measures 
 
Reproduced with permission. Clinical and cellular effects of hypothermia, acidosis and coagulopathy in 
major injury. Thorsen et al. British Journal of Surgery, 98(3).  
©2011 British Journal of Surgery Society Ltd. 
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Figure Legend 
Figure 2.1 Effects Leading to Trauma-Induced Coagulopathy 
Figure 2.2 Thromboelastography Measures 
Figure 2.3 Conceptual Model of Trauma, Hemorrhage, and Transfusion  
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CHAPTER THREE 
Association of Blood Component Ratio with Clinical Outcomes in Patients After Trauma 
and Massive Transfusion: A Systematic Review 
 
Synopsis 
Objective: To systematically review studies that compared clinical outcomes of patients 
after trauma that required massive transfusion (10 or more units of packed red blood cells 
in 24 hours) based on the ratio of blood components received. 
Summary Background Data: Hemorrhage is the primary preventable cause of death in 
trauma patients. Volume resuscitation includes infusion of crystalloids and transfusion of 
blood components (packed red blood cells, platelets, fresh frozen plasma). However, the 
most effective ratio of massively transfused components in trauma patients has yet to be 
determined.   
Methods: PubMed, CINAHL, and MedLine (Ovid) were searched for studies published 
between 2007 and 2014. We systematically reviewed selected studies using an adapted 9-
item instrument to assess bias in observational studies. Patient outcomes were determined 
and compared based on ratio of components transfused. 
Results: Twenty-one studies were included in the analysis; only two were prospective, 
the remaining 19 were retrospective. The average bias score for the studies was 2.86 ± 
1.39 out of a maximum of 16, indicating low risk for bias among the investigations. The 
most common sources of potential bias were lack of data about primary outcomes and 
adverse events. Transfusion of components in a 1:1:1 fashion was associated with a 
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survival benefit during hospitalization, but findings were equivocal for clinical outcomes 
such as ventilator days and length of stay. 
Conclusions: Transfusion of blood components in a 1:1:1 ratio is associated with 
improved survival in patients with trauma who required massive transfusion. The effect 
of component ratio on other clinical outcomes requires further investigation.  
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Introduction 
Trauma is the fifth leading cause of death for people of all ages;(1) deaths 
attributed to unintentional traumatic injury totaled more than 187,000 individuals in the 
United States in 2011.(2) Trauma hemorrhage was responsible for approximately 50% of 
all trauma mortality in 2013,(3) and half of trauma deaths that occurred within the first 24 
hours after injury.(4, 5) Traumatic hemorrhage was often complicated by coagulopathy, 
which subsequently worsened the hemorrhage. Recent evaluation of a large trauma 
database revealed that based on international normalized ratio (INR) and partial 
thromboplastin time (PTT) values, 42% (INR) and 21% (PTT) of trauma patients, 
respectively, were coagulopathic on arrival to the emergency department (ED).(6) 
Coagulopathy has been associated with a 4-fold increase in risk of mortality in trauma 
patients.(7)  
 In 2014, investigators reported findings from the Clinical Randomization of an 
Antifibrinolytic in Significant Haemorrhage-2 (CRASH-2) clinical trial, which included 
outcomes of more than 27,000 trauma patients from 40 countries; they found that 
approximately 50% of these trauma patients required transfusion of at least one unit of 
packed red blood cells (PRBCs) for stabilization.(8) In 2011, trauma and emergency 
patients received 10.2% of all PRBC transfusions, and 4.4% of all platelet (PLT) 
transfusions given in American hospitals.(9) According to a recent study of multiple 
trauma centers, investigators found that approximately 14% of trauma patients who 
required transfusion received massive transfusion (MT) of blood components.(10) MT 
has been typically defined as transfusion of 10 or more units of PRBCs in a 24-hour 
period.(3, 10) Those patients who required MT after trauma hemorrhage were eight times 
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more likely to develop infection during hospitalization, compared to similarly injured 
patients who were not transfused (OR 7.97, 95% CI 2.3-27.5, p < 0.001).(11) Trauma 
patients who received MT also required an average of 5 days longer in the intensive care 
unit and a 14-day longer hospital length of stay, when compared with those similarly 
injured, but not transfused.(11) Thus, patients who required MT after trauma are a highly 
vulnerable population.  
Facilities with Level I trauma centers may use a MT protocol to guide 
management of severe hemorrhage. MT protocols commonly include policies to facilitate 
the rapid release and delivery of blood components to the patient. Protocols specify those 
who can activate the protocol, volume of blood components and ratio of components to 
be released and administered, required laboratory testing prior to and during 
implementation of the protocol, and outcomes to be evaluated.(12) However, not all 
trauma centers have these. In 2010, investigators found that although 85% of trauma 
centers had a MT protocol in place, the majority (65%) of these had been in place for less 
than five years.(13) Unfortunately, of those facilities with protocols, there was a serious 
lack of consistency in the number of units, types of components released, and ratio of 
components to be administered with activation of the protocol. To date, evidence-based 
practices for MT have not been comprehensively evaluated and synthesized. Thus, the 
aim of this review was to systematically analyze studies where outcomes were compared 
based on ratios of blood components administered to adult trauma patients who required 
MT at Level I or major trauma centers in both military and civilian institutions. 
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Methods 
We searched PubMed, CINAHL, and MedLine (Ovid) using the key words blood, 
massive transfusion, emergency, trauma, and ratio, and included studies that: 1) were 
published in English between 2007 and 2014; 2) were performed at military or civilian 
Level I or major trauma centers; 3) focused solely on adult trauma patients who received 
massive transfusion as defined by the investigator; and 4) compared outcomes of groups 
based on the ratio of blood components administered. The initial search resulted in a total 
of 664 articles. Examination of title and abstract for relevance, and exclusion of 
duplicates resulted in 33 articles for inclusion. Hand search and further evaluation of the 
studies for inclusion limited the review to 21 published studies (Figure 1).  
We evaluated the risk of bias in the reviewed studies using a 9-item instrument 
based on Viswanathan and Berkman,(14) who identified indicators of bias in 
observational studies (Table 1.). Each published study was evaluated independently by 
two reviewers for 9 items that evaluated for risk of bias; four items were scored 0 to 1; 
three items were scored 0 to 2; two items were scored 0 to 3. Item scores were summed 
for a total score, which ranged from 0 to 16; higher scores indicated greater risk for bias. 
Scores from the two independent reviewers agreed in 98% of cases. Discrepancies in 
scoring were discussed until 100% agreement was reached. 
Quality of Studies 
 This review included 21 studies (Table 2.). Only two of the included 
investigations (15, 16) were prospective; all others were retrospective medical record or 
database reviews.(17-35) Seven studies (32%) used multicenter data for their 
analyses.(16, 20, 22, 27, 30, 32, 33) The majority of studies were performed in the United 
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States (62%)(15, 16, 18-21, 23, 25-27, 30, 31, 33) and in civilian trauma centers 
(57%).(15, 16, 18-21, 23, 25-27, 30, 31)  Studies performed outside of the United States 
included those from Germany;(22, 32) Australia,(28) and Japan.(35) Three studies were 
performed in Combat Support Hospitals in Iraq;(17, 24, 34) the investigators of a fourth 
military study did not disclose the location or source of their data collection, but 
identified the patients as injured in combat.(29)  
 In general, the risk of bias for these studies was low. The scores for these studies 
ranged from 0 to 4 with a mean score of 2.86 ± 1.39 (Table 2). Military studies had a 
higher risk of bias, with a mean score of 3.75 ± 0.5. The most common sources of 
potential bias were lack of reporting of primary outcomes like mortality and length of 
stay, and adverse events like sepsis and acute respiratory distress syndrome, with only 
five investigations reporting appropriate primary outcomes (22, 30, 32, 33, 35) and five 
reporting suitable adverse events.(16, 22, 32, 33, 35)  
 The mean sample size of these studies was 424 ± 280 participants, with a range of 
21 to 1,250 participants; therefore, adequate sample sizes were available for the majority 
of studies. A mixture of blunt and penetrating trauma patients were included among the 
majority of studies, with a larger portion of the study population in military studies 
involving penetrating injuries.(17, 24, 34) Sperry and colleagues (16) and Brown and 
colleagues (33) included only patients with blunt trauma. Investigators for 2 studies did 
not report the proportions of blunt versus penetrating trauma.(26, 29) Evidence exists to 
suggest that blunt trauma patients experienced different mechanisms of tissue and organ 
injury compared to those with penetrating trauma, with the probability of transfusion 
likely differing between the groups.(36, 37) Thus, comparison of findings among studies 
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in this review involving a mixture of patients who suffered blunt and penetrating injuries 
is limited, as it is highly likely that the extent of their injuries and course of treatment 
varied.  
While the majority of investigators (81%) used the same definition of MT, 10 or 
more units of PRBCs in a 24-hour timeframe, (15, 17-20, 23-27, 29-35) investigators for 
nearly one fifth of studies (18%) defined MT differently; thus, meta-analysis was not 
possible. Definitions ranged from a minimum of 5 (28) to 10 (22) units of PRBCs during 
a period defined either by the hours following injury (e.g. the first 12 hours (16)), the 
hours following admission (ranging from 4 (28) to 6 (21)), or the patient location 
(between ED admission and transfer to the intensive care unit).(22) Thus, variation 
existed among investigators in the MT definition. 
 Investigators for 7 studies accounted for survival bias,(18, 20, 22, 23, 27, 30, 32) 
the concept that certain patients may have been more likely to die earlier than others 
because they did not live long enough to receive the treatments necessary for survival. 
These provisions included: exclusion of patients who died within a certain timeframe, i.e. 
following admission to the emergency room;(20, 27, 30, 32) exclusion based on the 
location of a patient when death occurred;(23) death occurring prior to admission to the 
intensive care unit;(22) and death prior to receipt of surgical intervention for injuries.(18) 
In contrast, some investigators argued that the first six hours of treatment were the most 
crucial to survival, as this was when coagulopathy correction occurred; thus, patients who 
died in this timeframe should have been included to inform the process of resuscitation 
and determine best practice.(21, 24)  
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 The use of biological variables among investigators to either characterize their 
sample, or control for confounding variables in their analyses ranged from none (19) to 
12 measures.(28) The most commonly used physiological measure was blood pressure, 
which was measured in 17 investigations.(15, 17, 18, 20, 22-24, 26-28, 30-35) Other 
biological variables less commonly used included: hemoglobin,(17, 21-24, 27-29, 32, 34, 
35) blood pH,(16, 20, 21, 24, 28, 30) temperature,(16, 17, 20, 21, 24, 28-30, 33, 34) heart 
rate,(17, 20, 24, 28-32, 34) respiratory rate,(28, 34) coagulation factors,(17, 20-25, 27-35) 
base excess/deficit,(16, 17, 20-25, 29-35) lactate,(21, 28, 31, 33, 35) platelet count,(17, 
20, 22, 24, 25, 27, 28, 30-32, 34, 35) white blood cell count,(22) fibrinogen,(27, 28) and 
bicarbonate level.(28) Such variation limited the ability to compare patients and the 
corresponding findings from the analyses. 
 In summary, there was a low risk of bias among the studies included in the 
review. However, comparison of findings across studies remained difficult due to several 
factors. Inclusion of both blunt and penetrating trauma patients in the majority of studies 
posed a challenge, as mechanisms of injury and the subsequent course of treatment and 
recovery may differ between the injury groups. Though the majority of investigators used 
the same MT definition, roughly 20% did not. Existing controversy surrounding survival 
bias analysis techniques further limits comparison of findings given the removal of 
patients from certain analyses based on early death. Finally, biological measures were not 
consistently reported among investigators; thus, there was an incomplete clinical picture 
of patients related to transfusion requirements and clinical outcomes. 
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Results 
Ratio of Blood Components Administered  
 Prior research evidence suggested that whole blood was superior to blood 
components for resuscitation of trauma patients, and that transfusion of a 1:1:1 ratio of 
PRBCs to FFP to PLTs was the closest approximation to whole blood, and was superior 
to the use of single components, or multiple components in a different ratio for 
resuscitation.(38-40) The ratio of blood components administered was used in these 
studies to group patients, and evaluate outcomes associated with the ratio of units of FFP 
to PRBC units, or units of PLTs to PRBCs. None of the MT protocols reported in these 
studies included prescription for transfused component ratio. The methods by which 
investigators chose ratio groupings for comparison purposes was largely arbitrary, with 
only five investigators citing former studies,(19, 24, 33-35) and investigators for two 
studies referred to their ratio groupings as clinically relevant without definition.(15, 27)  
 Investigators categorized ratios as high, medium, or low, used a numerical range, 
or included both strategies. A low ratio of FFP to PRBC ranged from < 1:1.5 (25, 31-33, 
35) to < 1:18 (15) indicating that for every unit of FFP, 1.5 to 18 units of PRBCs were 
administered. The medium range included values between > 1:8 to < 1:3,(26) > 1:18 to < 
1:12,(15) and < 1:1.5 to > 1:2;(35) this, again, translated into administration of 1 unit of 
FFP for every 1.5 to 18 units of PRBCs. There was obvious overlap with the low ratio 
group in some categorization schemas. The high ratio ranged from > 1:2,(25, 31, 32) to  > 
1:12 to < 1:6,(15) or < 1:2,(35) which would indicate that for every unit of FFP, < 2 to 12 
units of PRBCs were administered. The high ratio was considered the closest to the 1:1 
ratio intended to mimic whole blood; however, the variability in this definition was quite 
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large. Investigators for two military studies defined a low ratio as < 1:4,(29) or 1:8;(17) 
the high ratio was defined as > 1:2, and 1:1.4, respectively, indicating that for every unit 
of FFP, the patient received anywhere from 1.4 to 8 units of PRBCs. Given the wide 
range in definition of ratio groups and administration of components, comparison of 
findings among patients is limited. 
 The categorization of PLT:PRBC ratios was similar to that of FFP:PRBCs. Low 
ratios, the closest to the 1:1:1 ratio, ranged from < 1:18 (15) to < 1:2,(20) with one group 
of investigators using > 1:20 (30) as a low ratio category, which indicated that for each 
unit of PLTs, the patient received 2 to 18 units of PRBCs. Thus, these categorization 
strategies were also inconsistent. Few investigators used a medium range for PLT:PRBC 
ratios.(15, 24, 27, 30) Of those investigators who reported a medium ratio range, ratio 
values included > 1:18 to < 1:12,(15) 1:16 to < 1:8,(24) > 1:4 to 1:1,(27) and 1:2, 
meaning that patients received 1 to 18 units of PRBCs for each unit of PLTs 
received.(30) High ratios were equally as varied, and were defined as anywhere from > 
1:1(27) to > 1:12 to < 1:6, indicating that patients received 1 to 12 units of PRBCs for 
every unit of PLTs.(15) Inaba and colleagues (15) were the only investigators to include a 
highest ratio group, which consisted of a ratio > 1:6, which indicated that patients 
received more than 1 unit of PLTs for every 6 units of PRBCs transfused. As a result of 
the wide variety of ratio groupings and the lack of consistency in the methods by which 
groups were chosen, comparisons of outcomes based on component ratio was not 
possible.   
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MT and Outcomes 
Association of component ratio and mortality  
Mortality was evaluated at 6,(22, 27, 31-35) 12,(15, 33) and 24 hours,(15, 16, 22, 
24, 25, 27, 28, 30, 32-35) 30 days,(19, 22, 24, 27, 28, 30, 32, 34) and/or at hospital 
discharge.(15-18, 20, 21, 23, 25-29, 31, 32, 35) For the purpose of our review of  
findings, the mortality results from the latest point in hospitalization are presented and 
summarized from investigators who analyzed this outcome at multiple times. Ten of the 
17 investigators (59%) who focused on FFP:PRBC ratios ultimately concluded there was 
significant survival benefit when the FFP:PRBC ratio neared 1:1; the decrease in 
mortality ranged from 4% to 64%.(17-20, 22, 23, 26, 27, 32, 33) (See Figure 2.) In 
contrast, investigators for seven studies (41%) found no difference in mortality based on 
FFP:PRBC ratio groups.(16, 21, 25, 28, 29, 31, 35) Holcomb and colleagues (20) found 
that a FFP:PRBC ratio of > 1:2 was associated with a 20% higher 30-day survival among 
a mixture of military and civilian patients; while Borgman and colleagues (17) identified 
an average mortality reduction of 46% when military patients received a ratio closer to 
1:1 compared with those who received a ratio further from 1:1. In contrast, Van and 
colleagues found no difference in mortality based on component ratio in military trauma 
patients.(29)  
 Investigators who studied the association of PLT:PRBC reported similar findings;  
investigators for seven of the eight studies (88%) concluded that there was superior 
survival for both military and civilian patients who received PLT:PRBC ratio closest to 
1:1.(15, 19, 20, 24, 27, 30, 33) (See Figure 3.) Differences in mortality rates between 
ratio groups were less dramatic than those reported for FFP:PRBC ratios, and ranged 
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from 8%(33) to 49%.(15) Only one group of investigators did not find a significant 
difference in mortality between high and low ratio groups.(34) Interestingly, this study 
included only combat casualties. These investigators reported an inability to perform 
time-dependent analyses, and a lack of data to permit control of crystalloid infusion 
volume; thus, the difference in findings may be a function of lack of control for 
confounding variables.(34) In summary, administration of blood components close to 
1:1:1 for PRBCs:FFP:PLTs was significantly associated with reduced mortality at 6,(22, 
27, 32, 33) 12,(15, 33) and 24 hours,(15, 22, 24, 27, 30, 32, 33) 30 days,(19, 22, 24, 27, 
30, 32) and at hospital discharge in the majority of these studies.(15, 17, 18, 20, 23, 26, 
27, 32) 
Association of component ratio and clinical outcomes 
 Clinical outcomes in addition to mortality were evaluated by investigators for 15 
of 21 studies (71%).(16, 17, 20, 22-25, 27-30, 32-35) Investigators in 9 studies focused 
on outcomes for those receiving FFP:PRBC high and low ratios;(16, 17, 22, 23, 25, 28, 
29, 32, 35) three other studies were focused on PLT:PRBC ratios,(24, 30, 34) and another 
three studies were focused on patients who received both FFP:PRBC and PLT:PRBC 
ratios.(20, 27, 33) The most frequently reported outcomes among these 15 investigations 
included multiple organ failure,(16, 17, 20, 22, 24, 25, 30, 32-34) intensive care unit 
(ICU) length of stay, alternatively reported as ICU-free days,(16, 20, 22, 23, 28, 30, 32, 
33, 35) hospital length of stay, alternatively reported as hospital-free days,(16, 20, 22, 28, 
30, 32, 33, 35) and ventilator days or hours, alternatively reported as ventilator-free days 
or hours.(16, 20, 22, 27, 28, 30, 32)  
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 Investigators for 3 studies found significant differences in rates of multiple organ 
failure between a high ratio (closer to 1:1) and a low ratio (two FFP:PRBC studies, one 
PLT:PRBC study).(22,30,34) Those in the low ratio groups experienced an average 
multiple organ failure rate of 27%, compared to those in the high groups who 
experienced an average rate of 47%.(22, 30, 34) Investigators for 4 studies found 
significant differences between FFP:PRBC ratio groups, with those who received high 
ratios experiencing hospital lengths of stay averaging 15.5 days longer than those in the 
low ratio groups.(16,22,32,33) Holcomb and colleagues reported a greater average of 
hospital-free days for those who received a combination of high FFP:PRBC and high 
PLT:PRBC ratios (6 ± 8 days) compared with those who received high FFP:PRBC but 
low PLT:PRBC ratios (3 ± 6 days), and for those who received a combination of low 
FFP:PRBC with high PLT:PRBC (5 ± 8 days) compared with those who received low 
FFP:PRBC but low PLT:PRBC ratios (3 ± 7 days, p < 0.001 across all groups).(20)   
 The average ICU length of stay reported in days was 15.5 ± 4.4 for high ratio 
groups and 14.1 ± 6.3 days for low ratio groups; average ICU-free days numbered 7.5 ± 
3.5 days for high ratio groups and 5.5 ± 3.5 days for low ratio groups. However, findings 
related to ICU length of stay related to ratio groups in individual studies were mixed. 
Investigators for four studies reported a greater length of stay averaging 4.6 days longer 
for those who received a high FFP:PRBC ratio (closer to 1:1) compared with those who 
received a low ratio,(16, 22, 28, 32) and one investigator for another study reported 
greater length of stay for those in the high PLT:PRBC ratio group versus the low (high 18 
days, low 15 days, p < 0.01).(33) However, more ICU-free days (shorter length of stay) 
were reported for patients who received high ratios for both FFP:PRBC and PLT:PRBC 
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(average 5 ICU-free days) compared with low (average 3 ICU-free days),(20) as well as 
for those who received high PLT:PRBC only (high, average 10 ICU-free days vs low, 
average 8 ICU-free days).(30)   
 Findings related to ventilation time were similarly varied. Investigators in 7 
studies reported significant differences in ventilation duration between high and low ratio 
groups. The average number of ventilator days was 12 ± 3.6 for those in high ratio groups 
and 7.8 ± 5.6 days for those in low ratio groups;(16,22,28) patients in the high ratio 
groups experienced an average of 9.5 ± 2.9 ventilator-free days compared to an average 
of 6 ± 2.9 ventilator-free days for those in low ratio groups.(20,27,30,32) Four of the 15 
investigations (27%) identified no difference between the ratio groups for any clinical 
outcome evaluated.(17, 24, 25, 35)  
 Therefore, while administration of components in a 1:1:1 fashion may be more 
beneficial to survival, those who do survive could experience greater complication rates, 
hospital/ICU length of stay, and greater ventilator days. Greater complication rates and 
lengths of stay may be due to the severity of illness and/or the presence of comorbidities 
further complicating severity of illness. Alternatively, shorter lengths of stay and 
ventilation times for those in the low ratio groups may be the result of early deaths due to 
clinical complications or severe illness. Further research is required to fully understand 
this relationship. 
Discussion 
 MT protocols are still fairly new among trauma centers, but may be beneficial in 
guiding treatment of critically injured patients. Evidence exists to support a decrease in 
mortality,(41, 42) length of stay,(42) and ventilator days (42) with the use of MT 
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protocols in resuscitation of trauma patients. Though guidelines from the American 
College of Surgeons are available to aid practitioners in their methods of transfusion and 
development of MT protocols,(43) no standardized MT protocol is used across trauma 
centers. As a result, protocols lack consistency in the physiological requirements for 
activation and cessation of component delivery, the clinicians who may activate them or 
stop delivery of components, and the amounts of components delivered to the bedside 
upon activation. Furthermore, protocols do not prescribe ratios of components to be 
transfused, only the amounts released from the blood bank upon activation. Some 
investigators argue, however, that the treatment prescribed by MT protocols may not be 
applicable for all massively hemorrhaging patients;(44) thereby removing the need for 
consistency among protocols and allowing clinician discretion in administration of 
components as needed.  
 The most effective ratios of components transfused during MT for survival and 
outcomes benefits remains controversial as well. Our review suggested transfusion of 
components in a 1:1:1 fashion may produce superior survival in trauma patients, but 
could also result in prolonged lengths of stay and increased complications. Neal and 
colleagues (45) concluded that the evidence to support a 1:1:1 ratio of components was 
“impressive”, and recommended the use of a 1:1:1 ratio in resuscitation practices.  
 Investigators have found similar results in patients with both blunt and penetrating 
trauma, with those receiving closer to a 1:1:1 ratio experiencing better outcomes.(37) The 
same group of investigators suggested a more beneficial effect of the 1:1:1 ratio in male 
trauma patients compared with female, possibly as a result of inherent hormonal 
differences.(47) Mixed findings existed in the current analysis with regards to the three 
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military studies, potentially the result of different injury patterns and treatment methods, 
as compared to those experienced by civilian patients. Thus, further investigation is 
warranted to determine best practice in general in patients with trauma, and more 
specifically between the genders and in military versus civilian populations.   
 Studies included in this review were primarily retrospective or observational, with 
minimal bias issues. Two of the greatest sources of bias were in the reporting of primary 
outcomes and adverse events. This may be due to the wide range of outcomes and 
adverse events patients transfused after trauma experienced during hospitalization. The 
third source of bias was a lack of control of confounding variables in analyses, found in 
12 (57%) of the studies. This could be the result of limited data availability or missing 
data given the nature of retrospective studies, and the chaotic atmosphere surrounding 
trauma resuscitation. Alternatively, some investigators may have chosen to exclude 
confounding factors for unknown reasons.  
 In either case, a lack of confounding factors in over half of the studies greatly 
impaired comparison of findings. For example, Riskin and colleagues (47) included 10 
variables in their prediction model, including transfusion-related variables, age, and 
injury characteristics. Similarly, Perkins and colleagues included 12 variables much like 
those used by Riskin et al., but these investigators added laboratory coagulation values 
and body temperature.(24) In contrast, Gunter and colleagues used only three regression 
variables: Trauma Related Injury Severity Score, age, and the intra-operative ratio of 
transfused components.(19) More consistency among investigators in control of 
confounding variables in analyses is critical for valid findings and interpretations.  
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Another factor to be considered is the effect of survival bias. Survival bias 
presents major issues in data analysis and associated findings, especially in trauma 
resuscitation literature.(48) Though exclusion of patients prior to a certain time point (e.g. 
the first 30 minutes following admission) provides a more homogeneous sample, this also 
eliminates a specific type of patient/experience that may be vital to understanding the 
population and phenomenon of interest. Investigators suggest the use of time-dependent 
analyses such as Cox proportional hazards models to help reduce survival bias, using 
timeframes in which no patients died (e.g. total transfused volume in the first 24 hours 
following injury).(49) Use of such techniques may lead to alternate findings compared to 
more traditional techniques like logistic or linear regression. In fact, several investigators 
cited in this study found conflicting results in their own analyses, noting a survival 
benefit initially, but finding no survival benefit once adjusting for survival bias.(25, 31) 
Other investigators note the importance of including confounding factors related to 
transfusion but not involving the amount or ratio of components transfused that may be 
associated with patient survival, such as changes in hospital protocol calling for reduced 
crystalloid infusion or mandating earlier transfusion of certain components.(48)  
Though the findings in this review support 1:1:1 transfusion, it should be 
emphasized that all studies reviewed were retrospective or observational, and not all 
investigators found an increased survival benefit with this combination of components. In 
fact, it is due to the nature of studies such as these and the issues with survival bias that 
the Canadian National Advisory Committee on Blood and Blood Products determined in 
2011 that the evidence was not sufficient to warrant changes in their massive transfusion 
treatment recommendations to include a 1:1:1 transfusion ratio.(50) Randomized clinical 
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trials are thus required to determine best practice for this population; however, these are 
often time-sensitive and consume a tremendous amount of resources. Though few studies 
of this nature have been performed in patients with trauma who require massive 
transfusion due to economic, ethical, and logistic challenges, investigators believe it is 
possible despite these obstacles.(51, 52) 
Conclusion 
 The majority of evidence in our review supported transfusion of packed red blood 
cells, fresh frozen plasma, and platelets in a 1:1:1 fashion in massively hemorrhaging 
patients after trauma for superior survival. Clinical outcome benefits remain equivocal 
and require further investigation. Randomized controlled trials are necessary to 
adequately address transfusion practice in this population. 
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Table 3.1 Bias Assessment Instrument* 
Criteria Scoring Options 
Inclusion/exclusion criteria across groups Not applicable (0) 
No, does not vary across groups (0) 
Partially varies across groups (1) 
Cannot determine (2) 
Yes, varies across groups (3) 
Selection of appropriate comparison group Not applicable (0) 
Not inappropriate (0) 
Cannot determine (1) 
Yes, inappropriate (2) 
Valid/reliable measures used across groups Yes, valid/reliable measures used (0) 
Cannot determine or not reported (1) 
No, valid/reliable measures not used (2) 
Length of follow-up across groups Not applicable (0) 
No, not different; remedied through 
analysis (0) 
Yes, different or cannot determine (1) 
Important outcomes missing from results No, none missing (0) 
Cannot determine (1) 
Yes, some missing (2) 
Important harms or adverse events missing 
from results 
No, none missing (0) 
Not applicable to this study (0) 
Yes, some missing (1) 
Results believable Yes, believable (0) 
No, not believable (1) 
Attempts to balance groups Not applicable (0) 
Yes, accounts for imbalance statistically (0) 
No or cannot determine (1) 
Confounding variables missing from 
design 
No, taken into account (0) 
Partially – some included (1) 
Cannot determine (2) 
Yes, not accounted for or not identified (3) 
* Instrument based on Viswanathan M, Berkman ND. Development of the RTI item bank on risk of bias 
and precision of observational studies. J Clin Epidemiol. 2012 Feb; 65(2):163-78. 
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Table 3.2 Description of Included Studies (n = 21) 
Citation Setting MT Protocol/Definition Sample Methods Findings Quality 
Score 
Borgman 
et al. 
(2007) 
Unidentified 
Combat 
Support 
Hospital, 
Iraq 
- MT definition: 10 ≥ 
units PRBC or fresh 
whole blood within 24 
hours from admission 
- FFP:PRBC ratio groups 
chosen based on median 
ratios determined by 
bootstrapping technique: 
low (1:8), medium 
(1:2.5), high (1:1.4)  
- No MT protocol 
identified 
- Trauma patients 
admitted to combat 
support hospital 
who received a MT 
- N = 246; 94% 
penetrating 
injuries; 3 female 
patients; median 
age 24 years; 28% 
mortality 
Retrospective 
review of 
admissions in 
the Joint Theater 
Trauma 
Registry from 
between 
November 2003 
– September 
2005  
- Mortality of low, 
medium, and high 
groups were 65%, 
34%, and 19%, 
respectively (p < 
0.001) 
- Low plasma ratio 
group did not 
receive platelets; 
platelets only used 
in 27% of patients 
- Median time of 
death measured in 
hours from 
admission to the 
hospital was 2 
hours in the low 
group (IQR 1-4), 4 
hours in the 
medium group 
(IQR 2-16), and 38 
hours in the high 
group (IQR 4-155) 
(p < 0.001) 
- FFP:PRBC ratio 
independently 
associated with 
overall survival 
(OR 8.6, 95% CI 
2.1 – 35.2, p = 
0.003), as was base 
deficit (OR 0.89, 
95% CI 0.84 – 
0.95, p < 0.001) 
3 
Duchesne 
et al. 
(2008) 
Charity 
Hospital, 
New 
Orleans, LA 
- MT definition: > 10 
units PRBC in first 24 
hours of admission  
- FFP:PRBC ratio groups: 
patients grouped into 
those who received < 10 
units PRBC and those 
who received > 10 units 
PRBC during the first 24 
hours following injury; 
further divided into those 
receiving FFP:PRBC ratio 
of 1:1 and 1:4 
- Protocol activated by 
trauma surgeon; calls for 
6 units PRBC, 6 FFP, 6 
platelets, and 10 of 
cryoprecipitate 
 
- Adult trauma 
patients who 
required surgical 
intervention; 
Patients with ≤ 10 
units PRBC (N = 
250): 31 + 13, 85% 
male, 58% 
penetrating 
injuries, 17% died; 
Patients with > 10 
units PRBC (n = 
135): 33 + 11, 86% 
male, 72% 
penetrating 
injuries, 56% died 
Retrospective 
review of 
admissions to 
trauma intensive 
care unit 
between January 
2002 and 
December 2006 
- In patients who 
received > 10 units 
PRBC, significant 
difference in 
mortality in those 
patients with a 1:4 
ratio versus those 
with a 1:1 ratio 
(87.5% vs 26%, p 
= 0.0001) 
 
4 
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Table 3.2, Cont. 
Gunter et 
al. (2008) 
Vanderbilt 
University 
Medical 
Center, 
Nashville, 
TN 
 
- MT: ≥ 10 PRBC in first 
24 hours  
- Groups separated for 
analysis based on 
FFP:PRBC ratio: 0:1 – 
1:2.9; 
1:3 – 1:1.49; 1:1.5 – 0.9:1; 
≥ 1:1 
- 24-hr blood product use 
calculated; patients 
separated into groups based 
on FFP:PRBC and 
PLT:PRBC ratios 
intraoperatively and for 
first 24 hours after 
admission; outcomes 
evaluated for those with 
FFP:PRBC ratio of ≥ 2:3 
and PLT:PRBC ratio of ≤ 
1:5;  cut-points chosen 
based on previous studies 
- Attending trauma surgeon 
activates Trauma 
Exsanguination Protocol 
(TEP) 
- Protocol includes blood 
product ratio of: 10 units 
PRBC, 4 units AB negative 
FFP, 2 units PLT 
- Pre-TEP: n = 
140, median age: 
36 years (24-50), 
76% male, 61% 
penetrating 
injuries; Post-
TEP: n = 119, 
median age: 30 
(24-43), 75% 
male, 48% 
penetrating 
injuries 
Retrospective review 
of post-TEP protocol 
initiation admissions 
between Feb. 1, 2009 
and July 31, 2007; 
Comparison cohort of 
pre-TEP admissions 
selected from trauma 
admissions between 
August 1, 2004 and 
January 31, 2006  
- Both FFP:PRBC 
and PLT:PRBC ratios 
higher (closer to 1:1) 
for survivors 
- Patients with 
intraoperative and 
24-hr FFP:PRBC 
ratio ≥ 2:3 more 
likely to survive  
-Patients who did not 
achieve a PLT:PRBC 
ratio of ≥  1:5 less 
likely to survive  
- Lowest 30-d 
mortality was 
intraoperative 
FFP:PRBC ratio 
between 1:1.5 – 
1:1.01; significantly 
less than mortality 
rates for all other 
ratio ranges (p < 
0.001) 
 
4 
Holcomb 
et al. 
(2008) 
16 level-I 
trauma 
centers in 
the United 
States  
- MT definition: ≥ 10 units 
PRBC in 24 hours 
- Patients categorized by 
FFP:PRBC ratio and 
PLT:PRBC ratio 
- FFP:RBC ratio groups 
included low (<1:2) and 
high (≥ 1:2) 
- PLT:PRBC ratio groups 
included low (<1:2) and 
high (≥ 1:2) 
- Patients further grouped 
based on both FFP:PRBC 
and PLT:PRBC (1: high-
high; 2: high-low; 3: low-
high; and 4: low-low) 
- No protocols specified for 
any of the 16 centers 
- Patients who 
arrived from the 
scene of the 
trauma, and who 
received at least 1 
unit PRBC in the 
emergency 
department, 
irrespective of 
mechanism of 
injury (N = 467); 
- Excluded those 
who died within 
30 minutes of 
arrival (n = 1) 
leaving a total of 
466 MT patients 
for analysis 
- Mean age 39 ± 
18; 76% male; 
65% blunt injury  
- Retrospective multi-
center review of 
transfused trauma 
patients admitted 
between July 2005 
and June 2006 
 
- A FFP:PRBC ratio 
of ≥ 1:2 was 
associated with 
improved 30-day 
survival (40.4% vs 
59.6%, p < 0.01) 
- A PLT:PRBC ratio 
of ≥ 1:2 was 
associated with 
improved 30-day 
survival as well 
(40.1% vs 59.9%, p < 
0.01) 
- Group 1 (high-high 
ratios) had increased 
survival compared 
with the other 3 
groups at 6 and 24 
hours (p < 0.001) 
- Those who received 
high PLT:PRBC and 
FFP:PRBC ratios had 
increased ventilator-
free, ICU-free, and 
hospital-free days (p 
< 0.001) compared to 
those who received 
low PLT:PRBC and 
FFP:PRBC ratios 
4 
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Table 3.2, Cont. 
Kashuk 
et al. 
(2008) 
Denver Health 
Medical Center 
(DHMC), Denver, 
CO 
- MT definition: > 
10 units PRBC in 
first 6 hours after 
admission 
- FFP:PRBC ratio 
divided into 1:1, 
1:2, 1:3, 1:4, and 
≥ 1:5  
- No formal 
protocol in place 
at time of review 
- All patients 
undergoing 
massive 
transfusion; N = 
133; mean age 
34.9 + 17.1; 
overall mortality 
56%; death from 
penetrating 
trauma 41%; 
death from blunt 
trauma 59% 
- Retrospective 
review of trauma 
center’s registry 
and transfusion 
registry maintained 
by blood bank 
including patients 
admitted to DHMC 
from 2001 to 2006 
- Multiple logistic 
regression significant 
independent variables (p < 
0.05, OR 95%): PRBC 
units transfused at 6 hours 
(OR = 1.248, 1.038-
1.051), ED temperature < 
34° (OR = 15.491, 1.376 – 
174.396), age > 55 years 
(OR = 40.531, 5.315 – 
309.077) **instead of a 
linear correlation, followed 
a U-shaped relationship 
with death as an end point 
- Median FFP:PRBC ratio 
for all survivors was 1:2, 
and for non-survivors, 1:4 
- > 80% of transfusion 
requirements were 
completed within the first 
6 hours after ED admission 
3 
Maegele 
et al. 
(2008) 
70 hospitals in 
Germany 
contributing to the 
Trauma Registry of 
the Deutsche 
Gesellschaft für 
Unfallchirurgie 
(TR-DGU) 
- MT definition: 
minimum of 10 
units PRBC 
between ER 
arrival and ICU 
admission 
- Ratio 
definitions: 
Group 1 
(PRBC:FFP – 
ONLY STUDY 
TO REVERSE 
RATIO) > 1:1; 
Group 2 
(PRBC:FFP 0.9-
1.1 or 1:1); Group 
3 (PRBC:FFP < 
0.9 
- No protocol 
identified 
- Primary 
admissions to the 
trauma center; 
patients with ISS 
≥ 16, who met 
definition of MT 
(N = 713) 
- 69.7% male; 
mean age 40.1  
18; mortality 
Group 1 45.9%, 
Group 2 36%, 
Group 3 30.4%; 
blunt injury 
Group 1 92.3%, 
Group 2 87.7%, 
Group 3 97.4% 
- Retrospective 
review of data 
collected from TR-
DGU from 2002 to 
2006 
- All mortality rates (6 hr, 
24 hr, 30-day) were 
highest among Group 1 
(PRBC:FFP >1.1) 
- Acute (< 24 hr) and 30-
day mortality were lowest 
in patients who had a 
PRBC:FFP ratio < 0.9 
1 
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Table 3.2, Cont. 
Sperry 
et al. 
(2008) 
Seven 
institutions 
across the 
US 
- MT 
definition: ≥ 8 
units PRBC in 
first 12 hours 
after injury 
- Ratio 
definitions for 
FFP:PRBC 
were: high (≥ 
1:1.5), low (< 
1:1.5) 
- Low ratio 
group further 
broken down: 
1:2 (1:1.51 – 
1:2.5), 1:3 to 
1:4 (1:2.51 – 
1:4.5), and ≤ 
1:5 (≤ 1:4.51) 
- No protocol 
identified 
- Patients required ≥ 8 
units PRBC within the 
first 12 hours after injury, 
blunt mechanism of 
injury, presence of pre-
hospital or emergency 
department systolic 
hypotension or an 
elevated base deficit, any 
body region exclusive of 
the brain with an 
abbreviated injury score 
> 2, between ages of 16 
and 90 
- N = 415; median age 41 
(IQR 25-54); 76.5% male 
in the high group, 68.4% 
male in the low group; 
overall mortality 33.5%; 
median amount units 
blood transfused in first 
12 hours for entire cohort 
14 units (IQR 14-22) 
- Prospective cohort 
study: Inflammation 
and the Host Response 
to Injury Large Scale 
Collaborative Program 
supported by the 
National Institute of 
General Medical 
Sciences; patients 
admitted between 
November 2003 – 
March 2007 
- No statistically significant 
differences found in 
mortality between those 
receiving the high ratio and 
those receiving the low 
- Those who received a 
high ratio had a reduced 
blood transfusion 
requirement at 12 and 24 
hours post-injury (p = 
0.001) 
-Survival curves overall 
were not statistically 
significant; however, the 
mortality rate at day 1 post-
injury was significantly 
lower in the high ratio 
group (3.9% vs 12.8%, p = 
0.012) 
- Those who received a 
high FFP:PRBC ratio had a 
52% decrease in the 
likelihood of mortality (HR 
0.48, p = 0.002, 95% CI 0.3 
– 0.8); variation of the 
model to include only 
patients who received 
between 4-8 units of blood 
did not reach significance, 
indicating that the effect of 
the ratio may only apply to 
those being massively 
transfused 
2 
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Table 3.2, Cont. 
Duchesne 
et al. 
(2009) 
Unidentified 
Level-I urban 
trauma center 
in the United 
States 
- MT definition: 
≥ 10 units PRBC 
within 24 hours 
- Patients 
grouped 
according to 
ratio of 
FFP:PRBC (1:1, 
1:2, 1:3, 1:4) – 
no designation of 
“high” or “low” 
groups 
- MT protocol: 6 
units FFP and 6 
units PRBC 
available in the 
trauma bay; 
protocol 
activated by 
trauma surgeon 
- Patients with initial 
trauma induced 
coagulopathy 
diagnosed on arrival to 
the emergency 
department, who 
required FFP and > 10 
units PRBC in the OR 
during initial surgical 
intervention 
- N = 135; mean age 
35; 88.7% male; mean 
ISS 21.7; 68.7% 
penetrating trauma; 1:1 
group – 46 (34.1%), 
1:2 group – 26 
(19.2%), 1:3 group – 
20 (14.8%), 1:4 group 
– 43 (31.8%) 
- Retrospective 
review of trauma 
patients admitted 
between January 
2001 to 
December 2007 
- 31% of population 
diagnosed with trauma-
induced coagulopathy on 
arrival 
- No significant differences 
in demographic or clinical 
variables among groups 
- Patients in 1:4 group 
experienced 13 day 
increase in Trauma ICU 
length of stay compared 
with 1:1 group (p < 0.01) 
- Overall mortality per 
transfusion group: 1:1 – 
28.3%; 1:2 – 38.5%; 1:3 – 
40.0%; 1:4 – 51.2% 
- Overall mortality 
differences statistically 
significant between 1:1 
group (28.2%) and 1:4 
group (51.1%) (p = 0.03) 
- Mortality in operating 
room for 1:1 group was 
8.7% vs 34.9% in 1:4 
group (p < 0.01); mortality 
was similar between these 
groups after arrival to 
Trauma ICU 
- Patients in the 1:3 and 1:4 
ratio groups were 3.76 (p = 
0.03, 95% CI 1.18-11.9) 
and 4.17 (p < 0.01, 95% CI 
1.48 – 11.7) more likely to 
die in the operating room; 
risk of dying was not 
significantly different 
between groups after 
Trauma ICU admission 
3 
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Table 3.2, Cont. 
Perkins 
et al. 
(2009) 
US Army 
Combat 
Support 
Hospital at Ibn 
Sina Hospital in 
Baghdad, Iraq 
- MT definition: 
≥ 10 units of 
blood within 24 
hours 
- Patients 
grouped based on 
ratio of 
PLT:PRBC; low 
ratio (< 1:16), 
medium (1:16 to 
< 1:8), and high 
(> 1:8) 
- MT protocol in 
place to guide 
resuscitation; not 
specified further 
- Patients who 
received ≥ 10 of 
blood within 24 
hours; excluded 
those who received 
fresh whole blood 
- N = 464; Median 
age 27-28; > 95% 
male, median ISS 
20 – 21, > 90% 
penetrating trauma; 
214 patients were in 
the low ratio group, 
154 in the medium, 
and 96 in the high 
- Retrospective 
review of trauma 
patients admitted 
between January 
2004 – December 
2006 
- Survival at 24 hours was 
64%, 87% and 95% in the 
low, medium, and high ratio 
groups respectively (𝜒2, p < 
0.001 for low versus medium 
and high PLT ratio group 
comparisons, 𝜒2 , p = 0.04 for 
medium versus high PLT 
ratio group comparisons); 
most deaths in the first 24 
hours occurred within the 
first 6 hours after admission 
- 30-day survival differed 
between low (42.7%), 
medium (60%), and high 
(75%) groups as well (p < 
0.001, log rank comparison) 
- Variables independently 
associated with decreased 
mortality at 24 hours 
included: FFP ratio (OR, 
0.94, p < 0.001, 95% CI 0.91 
– 0.96), PLT ratio (OR, 0.82, 
p = 0.002, 95% CI 0.72 – 
0.93) 
4 
Snyder 
et al. 
(2009) 
University of 
Alabama-
Birmingham 
Hospital, 
Birmingham, 
AL 
-MT: ≥ 10 units 
of PRBC during 
the first 24 hours 
of admission 
- No ratio groups 
pre-defined  
- No protocol in 
place 
- All trauma 
patients massively 
transfused (N = 
134); Survivors (n = 
67) - mean age 
36.8, 64.2% male, 
40.3% blunt injury; 
Non-survivors (n = 
67) – mean age 
41.6, 77.6% male, 
38.8% blunt injury 
- Retrospective 
chart review of 
admissions between 
January 2005 and 
January 2007;to 
calculate ratio of 
blood products used 
in resuscitation; 
formula used:  
FFP:PRBC ratio = 
F/(B+C) where C 
represents total  
auto-transfused cell 
saver units 
- 68% of 24-hour totals were 
given in the first 6 hours of 
admission; 92% in the first 
12 hours 
- First PRBC unit given at a 
median of 18 mins; first FFP 
unit given at a median of 93 
mins 
- Patients in high-ratio group 
had a significantly lower risk 
of death compared with low-
ratio group (RR, 0.37; 95% 
CI 0.22-0.64) 
- Majority of deaths for low-
ratio group occurred within 
the first 6 hours of 
admission; majority of deaths 
for high-ratio group occurred 
after initial 24 hours 
3 
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Table 3.2, Cont. 
Teixeira 
et al. 
(2009) 
Los Angeles 
County + 
University of 
Southern 
California 
Medical 
Center, Los 
Angeles, CA 
- MT: > 10 units 
PRBC during the 
initial 24 hours 
after admission 
- Four groups of 
FFP:PRBC ratios: 
Low (< 1:8), 
Medium (> 1:8 
and < 1:3), High 
(> 1:3 and < 1:2), 
Highest (> 1:2) 
- No MT protocol 
in place during 
study period 
- Trauma patients 
receiving MT without 
severe head injury; N 
= 383; mean age 32 + 
15; 87% male;  
- Retrospective 
study using 
Trauma Registry 
and the Blood 
Bank Database, 
between 2000-
2005 
- Mean units FFP per 
patient increased 83% from 
2000 to 2005 (not 
statistically significant, p = 
0.07) 
- FFP:PRBC second most 
important predictor of 
outcome after GCS on 
admission (Adj OR = 0.02, 
95% CI 0.01 – 0.07, R2 = 
0.47, ROC = 0.86) 
- Increased likelihood of 
death if the FFP:PRBC 
ratio < 1:3 
- Mean ratio for survivors 
was 1:2.1 compared with 
1:3.7 for non-survivors (p 
< 0.001) 
4 
Zink et 
al. 
(2009) 
16 level-I 
trauma centers 
across the US 
- MT: ≥ 10 units 
PRBC in the first 
24 hours after 
injury 
- Ratio definitions 
for both 
FFP:PRBC and 
PLT:PRBC were: 
Low (< 1:4), 
Medium (≥ 1:4 to 
1:1), High (≥ 1:1) 
- No protocol 
specified 
- All trauma patients 
age 16 and older who 
received any PRBCs 
within 24 hours of 
admission; excluded 
those who died within 
30 minutes of arrival 
- N = 452; mean age 
for FFP:PRBC 
patients ranged from 
28.3 - 36; for 
PLT:PRBC patients 
ranged from 34-36; > 
70% male for both 
FFP:PRBC and 
PLT:PRBC groups; 
overall mortality 41% 
- Retrospective 
review of trauma 
patient records 
from those injured 
between July 2005 
and June 2006 
- Patients who received a 
FFP:PRBC ratio of < 1:1 
within the first 6 hours 
after admission required a 
median of 18 units of 
PRBC throughout the first 
24 hours; those who 
received a ratio of ≥ 1:1 
only required a median of 
13 units PRBC (p < 0.001) 
- No significant differences 
seen in respiratory 
outcomes based on ratio of 
FFP:PRBC or PLT:PRBC 
4 
Inaba et 
al. 
(2010) 
Los Angeles 
County + 
University of 
Southern 
California 
Medical 
Center, Los 
Angeles, CA 
- MT: ≥ 10 units 
PRBC during 
initial 24 hours 
after admission 
- aPLT:PRBC 
Ratio definitions 
defined: Low (< 
1:18), Medium (> 
1:18 to < 1:12), 
High (> 1:12 to < 
1:6), and Highest 
(> 1:6) 
- No protocol 
identified 
- All trauma patients 
receiving a PRBC 
transfusion; N = 657; 
12.6% > 55 years; 
83.6% male; 54.8% 
penetrating trauma; 
Low ratio N = 171; 
Medium ratio N = 77; 
High ratio N = 249; 
Highest ratio N = 160 
- Prospective 
study; 9-year 
observation period 
ending December 
2008 
- As the aPLT ratio 
increased, a step-wise 
decrease in mortality was 
seen (72.1% to 33.1%, adj. 
p < 0.001) 
- aPLT:PRBC ratio 
independently associated 
with improved survival at 
24 hours (OR 0.92, CI 
0.89-0.95), (R2  = 0.54) 
- Highest ratio group 
14.2% 12-hr mortality vs 
Low ratio group 48.2% 12-
hr mortality (adj. p < 
0.001) 
3 
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Table 3.2, Cont. 
Mitra et 
al. (2010) 
Alfred 
Emergency & 
Trauma Centre, 
Victoria, 
Australia 
- MT: ≥ 5 units 
PRBC transfused 
within the first 4 
hours 
- FFP:PRBC ratio 
groups: >1:1.5, 
>1:2.5 to 1:1.5, 
>1:3.5 to 1:2.5, ≤ 
1:3.5 
- MT protocol: 4 
units PRBCs and 
4 units (600 mL) 
of FFP (1:1 ratio) 
– was not audited 
or formally used 
during study 
period 
- All trauma patients 
who presented to the 
emergency department 
and received MT (N = 
331) 
- Mean age 42.1 ±19.3, 
86.4% blunt trauma, 
68.3% suffered head 
injuries, 29.9% 
mortality 
- Retrospective 
review of patient 
records from the 
Alfred Hospital 
database from 
July 2004 – 
August 2008 
- No significant 
differences in mortality 
among the ratio groups 
- The FFP:PRBC ratio in 
the first 4 hours was not 
significantly associated 
with overall mortality 
4 
Van et al. 
(2010) 
No location 
specified; 
protocol 
approved by 
Institutional 
Review Board at 
Brooke Army 
Medical Center 
- MT: > 10 units 
PRBC in 24 
hours; one unit 
fresh whole blood 
(FWB) equivalent 
to one unit PRBC 
and one unit FFP 
- Groups based on 
FFP:PRBC ratio: 
low (<1:4), mid 
(1:4 to 1:2), high 
(>1:2) 
- No protocol 
identified 
-All patients with 
isolated extremity 
injuries who received 
at least 1 unit PRBC (N 
= 703) 
- MT: mean age 25.7, 
heart rate 117, 
temperature 97.6, base 
deficit 8.0; Non-MT: 
mean age 25.8, heart 
rate 99, temperature 
98.2, base deficit 3.7 
- MT mortality 17.2% 
(low ratio), 8.5% (mid 
ratio), 6.9% (high 
ratio) 
- Retrospective 
review of database 
of combat-injured 
patients from 
March 3003 to 
June 2008 
- No significant 
differences in mortality 
rates among both the MT 
and non-MT ratio groups 
- In non-MT population, 
those who received a low 
ratio had a significantly 
lower incidence of 
pulmonary embolus than 
those in the mid and high 
groups (1.4 vs 6.0 and 
1.4 vs 6.7, respectively, 
p < 0.05) 
4 
Holcomb 
et al. 
(2011) 
22 Level I 
Trauma Centers 
across the 
United States 
- MT: > 10 units 
PRBC within 24 
hours of 
admission; 
apheresis platelet 
unites were 
converted to 
pooled PLT (1 
aPLT unit = 6 
pooled PLT units) 
- Ratio definitions 
for PLT:PRBC 
groups: Low 
(>1:20), Medium 
(1:2), and High 
(1:1) 
- No protocol 
identified 
- All patients admitted 
directly to the 
emergency department 
from the scene of 
injury who received at 
least one unit of PRBC 
in the emergency 
department (N = 643); 
excluded those who 
received MT and died 
within 60 minutes of 
arrival 
- Mean age 39 + 18; 
75% male; 66% blunt 
trauma; mean ISS 33 + 
16; 30 day survival 
60%; 24 hour survival 
72%; 6 hour survival 
83% 
- Overall survival by 
group: 50% (Low); 
55% (Medium); 69% 
(High) 
- Retrospective 
multicenter 
institutional 
review of trauma 
patients admitted 
between July 2005 
and June 2006 
- Increased PLT ratios 
were associated with 
improved survival at 6 
hours, 24 hours, and 30 
days (p < 0.001 for all 
groups)  
-70% of those who died 
within 30 days of 
admission died within 
the first 24 hours 
following admission; 
50% died within the first 
6 hours of admission 
- Median transfusion 
rates were clinically 
similar across the three 
groups indicating that 
patients were bleeding at 
approximately the same 
rate 
- Patients in the low and 
medium ratio groups 
experienced a higher risk 
of mortality compared 
with those in the high 
ratio group (RR = 2.81, 
95% CI 1.36-5.8, p = 
0.005 and RR 3.13, 95% 
CI 1.52-6.45, p = 0.002 
respectively) 
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Table 3.2, Cont. 
Magnotti 
et al. 
(2011) 
Presley 
Memorial 
Trauma 
Center 
(PMTC), 
Shelby 
County, TN 
- MT: > 10 units of 
PRBC during the first 
24 hours of admission  
- FFP:PRBC Ratio 
definitions: Low (< 
1:2), High (> 1:2) 
- Rapid Infusion 
System protocol: 
anesthesiologist will 
receive 10 units each 
of PRBC, FFP, and 
PLT  
 
- Patients admitted to 
the trauma center after 
trauma activation (N = 
103); mean age 38; 
69% male; 63% blunt 
trauma; Survivors n = 
57; Non-survivors n = 
46; High-Ratio n = 66; 
Low-Ratio n = 37 
Retrospective 
review of the 
resuscitation 
registry at PMTC 
between March 
2008 and December 
2007 
- 59% low-ratio 24-hr 
mortality; 38% high-
ratio 24-hr mortality 
- 6-hr mortality was 
10% in high-ratio 
patients vs 48% in 
low-ratio group (p < 
0.002); cause of death 
within the first 6 hours 
was uncontrolled 
hemorrhage 
- After those deaths 
that occurred within 
the first 6 hours, both 
groups (high- and low-
ratio) were clinically 
similar from 6 to 24 
hours 
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Table 3.2, Cont. 
Peiniger 
et al. 
(2011) 
116 trauma centers 
contributing to the 
Trauma Registry of 
the Deutsche 
Gesellschaft für 
Unfallchirurgie 
(TR-DGU) 
- MT: > 10 
units of 
PRBC 
during the 
first 24 hours 
of admission 
- FFP:PRBC 
ratio groups: 
High (>1:2), 
Low (< 1:2) 
- No protocol 
identified 
- Patients admitted to the 
hospital directly from 
scene of injury who were 
> 16 years of age who 
suffered severe injury (ISS 
> 16 and received MT 
prior to ICU admission (N 
= 1,250); excluded those 
who died within first hour 
after admission; broken 
down into those with 
traumatic brain injury 
(TBI) and those without; 
mean age 42 + 16 years; 
72% male; mean ISS 42 + 
15; 90% blunt trauma 
- Overall mortality for 
those with TBI: Low 
group 62%, High group 
46% 
- Overall mortality for 
those without TBI: Low 
group 48%, High group 
27% 
Retrospective 
analysis of all 
trauma patients 
admitted 
between 2002 
and 2008 
- 80% of patients presented 
with signs of coagulopathy 
on admission to the 
emergency department 
- Mortality rate was lower 
across all time points in the 
High group compared to 
the Low group, regardless 
of presence or absence of 
TBI 
- High FFP:PRBC (>1:2) 
ratio found to have survival 
benefit in those who 
suffered a TBI (OR 0.48, 
95% CI  0.29-0.81, p = 
0.006), but not in those 
who did not suffer a TBI 
- Those in the High ratio 
group experienced a greater 
amount of ventilator-free 
days compared with those 
in the Low ratio group; this 
was true for both TBI and 
non-TBI groups (TBI group 
– High ratio: 6 + 9 days vs 
Low ratio: 4 + 8 days, p = 
0.006; non-TBI group – 
High ratio: 13 + 12 days vs 
Low ratio: 9 + 11 days, p < 
0.001) 
- Those in the High ratio 
group also experienced 
significantly longer ICU 
and hospital length of stay 
compared with those in the 
Low ratio group; again, this 
was true for both TBI and 
non-TBI groups (TBI group 
– High ratio: 18 + 21 days 
vs Low ratio: 13 + 19 days, 
p < 0.001; non-TBI group – 
High ratio: 19 + 20 days vs 
Low ratio: 15 + 19 days, p 
< 0.001) 
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Table 3.2, Cont. 
Brown 
et al. 
(2012) 
7 institutions 
contributing to the 
Inflammation and 
Host Response to 
Injury Large Scale 
Collaborative 
Program (Supported 
by the National 
Institute of General 
Medical Sciences, 
National Institutes of 
Health, United 
States) 
- MT: > 10 
units of PRBC 
during the first 
24 hours of 
admission 
- FFP:PRBC 
ratio groups: 
High (> 1:1.5) 
and Low 
(1:1.51-2.5) 
- PLT:PRBC 
ratio groups: 
High (> 1:9) 
and Low (< 
1:9) 
- A 6-pack of 
PLT was 
counted as 1 
unit 
- No specific 
protocol 
identified; 
“Standard 
operating 
procedures” 
developed and 
followed by all 
institutions 
- Patients who suffered blunt 
trauma only, pre-hospital 
hypotension (SBP < 90 
mmHg) or elevated base 
deficit (> 6 mEq/L), blood 
transfusion required within 
first 12 hours following 
admission, and any body 
region except the head with 
and AIS score of > 2; 
between the ages of 18-90 
- N = 604; Overall mortality 
at 6-hours 9%, 12-hours 12%, 
24-hours 13%; High 
FFP:PRBC group: mean age 
43 + 20; 72% male; mean ISS 
40 + 16; 6-hour mortality 4%; 
Low FFP:PRBC group: mean 
age 43 + 18; 70% male; mean 
ISS 35 + 15; 6-hour mortality 
10%; High PLT:PRBC group: 
mean age 44 + 18; 65% male; 
mean ISS 36 + 16; 6-hour 
mortality 2%; Low 
PLT:PRBC group: mean age 
43 + 19; 72% male; mean ISS 
36 + 15; 6-hour mortality 
10%  
Retrospective 
analysis of 
patients 
admitted 
between 2003-
2010 
- Higher ratio of 
FFP:PRBC was 
associated with 
reduction in mortality 
(HR 0.19, 95% CI 
0.06 – 0.56, p < 0.01) 
- Higher ratio of 
PLT:PRBC also 
associated with 
independent 
reduction in mortality 
(HR 0.02, 95% CI 
0.01 – 0.50, p = 0.03) 
- When compared 
with those who 
received a Low 
FFP:PRBC ratio, 
those who received a 
High ratio of 
FFP:PRBC 
experienced a 
reduction of both 6-
hour (HR 0.19, 95% 
CI 0.03 – 0.86, p = 
0.03) and 24-hour 
mortality (HR 0.25, 
95% CI 0.06 – 0.95, p 
= 0.04) 
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   69 
Table 3.2, Cont. 
Cap et 
al. 
(2012) 
Ibn Sina 
Hospital – 
United 
States 
combat 
support 
hospital in 
Baghdad, 
Iraq 
- MT: > 10 units 
of PRBC within 
24 hours of 
admission 
- aPLT:PRBC 
ratio groups: Low 
(< 1:10) and High 
(> 1:10); one 
aPLT unit was 
equal to 5 units 
(range 4-6) of 
whole blood PLT 
- No protocol 
identified 
- Combat casualties admitted 
directly from scene of injury 
(N = 414); Overall mortality 
27%; Low group: age* 26 
(21-31) 28; 99% male; ISS* 
20 (12-28) 23; 93% 
penetrating injury; 24-hour 
survival 78%; 30-day survival 
71%; High group: age* 26 
(21-31) 28; 93% male; ISS* 
25 (18-32) 24; 89% 
penetrating trauma; 24-hour 
survival 90%; 30-day survival 
81% 
Retrospective 
review of 
admissions 
between January 
2004 and 
December 2006 
- Those in the High group 
received more overall 
blood products (PRBC, 
FFP, aPLT, 
cryoprecipitate) compared 
with the Low group (p < 
0.01), but also received 
products earlier than those 
in the Low group 
- 24-hour survival 
significantly greater in the 
High group compared to 
the Low group (90% vs 
78% (p = 0.02); no 
significant differences 
between the groups at 30-
days (81% vs 71%, p = 
0.08) 
- Most deaths occurred 
within the first 6 hours 
following admission – 
31% of those in the High 
group vs 68% of those in 
the Low group 
- Airway deaths (15.4% vs 
3.1% Low, p < 0.05) and 
multi-organ failure 
syndrome (46.2% vs 
16.5% Low, p < 0.05) 
more commonly occurred 
in the High group 
compared with the low 
group 
- Those in the Low group 
experienced a higher 
mortality likelihood both 
at 24 hours (HR 4.25, 
95% CI 1.25 – 14.48, p = 
0.02) and 30 days (HR 
2.32, 95% CI 1.11 – 4.84, 
p = 0.025) compared to 
those in the High group  
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Table 3.2, Cont. 
Kudo 
et al. 
(2013) 
Tohoku 
University 
Hospital 
Emergency 
Center, 
Sendai, Japan 
- MT: > 10 units 
of PRBC within 
24 hours of 
hospitalization 
- Ratios were 
calculated based 
on amount of 
components 
received within the 
first 6 hours of 
admission 
- FFP:PRBC ratio 
groups: High 
group (> 1:1.5), 
Middle (1:2 – 
1:1.5), Low (< 
1:2) 
- No protocol 
identified 
- Trauma patients who required MT, 
patients who received interventions 
for hemostasis, surgery or trans-
arterial embolization (N = 21); 
Overall mortality 33%; age** 60 
(36.5-64.5); 67% male; ISS** 25 
(17.0-34.0); 19% blunt injury; High 
group: 44% mortality; age** 61 
(27.5-65.0); 44% male; ISS** 32 
(20.5-34.0); 100% blunt injury; 
Middle group: 17% mortality; age** 
56 (36.3-86.3); 83% male; ISS** 
24.5 (15.5-27.3); 83% blunt injury; 
Low group: 33% mortality; age** 
59.0 (35.8-61.8); 83% male; ISS** 
24.5 (15.8-39.8); 83% blunt injury 
Retrospective 
review of 
admissions 
between October 
2006 and 
September 2009 
- No significant 
differences among 
the groups for 
mortality (Log-
Rank: p = 0.555), 
ICU-free days at 
30 days (p  = 0.4), 
or hospital-free 
days at 60 days (p 
= 0.42) 
- Only one patient 
(High group) 
developed sepsis; 
no patients 
developed acute 
respiratory 
distress syndrome  
0 
* = data presented as: median (IQR) mean 
** = data presented as median (IQR) 
MT = massive transfusion; PRBC = packed red blood cells; FFP = fresh frozen plasma; PLT = platelets; aPLT = apheresis platelets; 
IQR = interquartile range; OR = odds ratio; CI = confidence interval; ED = emergency department; HR = hazard ratio; ICU = 
intensive care unit; ISS = Injury Severity Score; RR = risk ratio 
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Figure 3.1 Article Selection 
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Figure 3.2 FFP:PRBC Mortality by Ratio Groups 
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Figure 3.3 PLT:PRBC Mortality by Ratio Groups 
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Figure Legend 
Figure 3.1 Article Selection 
Figure 3.2 FFP:PRBC Mortality by Ratio Group 
Figure 3.3 PLT:PRBC Mortality by Ratio Group 
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CHAPTER FOUR 
Increased Mortality in Adult Trauma Patients Transfused with Blood Components 
Compared with Whole Blood 
 
Jones, A.R., & Frazier, S.K. (2014). Increased Mortality in Adult Trauma Patients 
Transfused with Blood Components Compared with Whole Blood. J Trauma Nurs; Jan-
Feb 21(1): 22-29. 
Copyright © 2014. Society of Trauma Nurses.  
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of Nursing Research or the National Institutes of Health. 
Synopsis 
 Hemorrhage is a preventable cause of death among trauma patients, and 
management often includes transfusion, either whole blood or a combination of blood 
components (packed red blood cells, platelets, fresh frozen plasma). We used the 2009 
National Trauma Data Bank to evaluate the relationship between transfusion type and 
mortality in adult major trauma patients (n = 1745). Logistic regression analysis 
identified three independent predictors of mortality: Injury Severity Score, emergency 
transfer time, and type of blood transfusion, whole blood or components. Transfusion of 
whole blood was associated with reduced mortality; thus, may provide superior survival 
outcomes in this population.    
 
 
	  	   76 
 Introduction 
 Trauma is the leading cause of death for individuals aged 1-44 years.(1) 
Exsanguination is the primary cause of preventable death;(2-5) traumatic hemorrhage 
accounts for 35% of pre-hospital deaths, and more than 40% of deaths that occur within 
the first 24 hours after injury.(5) Transfusion of whole blood or blood components is the 
primary means of managing hemorrhagic shock that results from traumatic injury, in 
conjunction with effective control of bleeding. Yet, there is a lack of evidence to support 
the most appropriate type of trauma resuscitation transfusion, whole blood or blood 
components, which includes packed red blood cells (PRBCs), platelets (PLTs), and fresh 
frozen plasma (FFP).  
 Approximately 5 million individuals receive blood or component transfusions in 
the United States each year, with nearly 24 million units transfused annually.(6, 7) An 
average transfusion of PRBCs requires approximately three pints of donated blood, and a 
single trauma patient may require up to 100 units of PRBCs during resuscitation.(6) In 
2011, whole blood transfusions accounted for only 0.15% of total transfusions; thus, 
blood components are the primary choice for transfusion.(8) In addition, 10.2% of all 
PRBC transfusions and 4.4% of all PLT transfusions were used by the 
Trauma/Emergency Department (ED) services.(8) The average cost of a unit of PRBCs 
was $225.42 and a unit of apheresis PLTs was $535.17.(8) Thus, transfusion consumes 
increasingly scarce financial resources and requires the continuing generosity of millions 
of donors annually.   
 An association between blood transfusion and greater mortality has been 
previously reported.(9, 10) Kapan and colleagues found that in patients who required 
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damage control surgery for trauma, transfusion volume was an independent predictor of 
mortality; those who died received 3 more units of blood than those who survived, in 
spite of similar injury severity score (ISS).(11) Cripps and colleagues found that in 
trauma patients who required activation of the massive transfusion protocol, those who 
died received 8 more units of PRCs, and the ratio of PRCs to FFP was also significantly 
greater (1.47/1.94).(12) However, those who died had a significantly higher admission 
ISS and a lower Glasgow coma score; thus, those who died were more severely injured. 
In a recent review of trauma transfusion practices over 6 years, Kutcher and colleagues 
identified a decrease in the volume of crystalloids infused, in conjunction with an attempt 
to emulate whole blood, using the combination of PRCs, FFP and platelet infusion; each 
reduction of 0.1 in the ratio of PRC/FFP was associated with a 6% reduction in 
mortality.(13) Thus, there is evidence to support the importance of not only the volume of 
transfusion, but also the type of blood transfused in trauma patient outcomes.  
 Researchers recently suggested that the transition from transfusion of whole blood 
to blood components during trauma resuscitation occurred without sufficient evidence to 
support this ubiquitous change in practice.(14) The transition to component transfusion 
occurred as longer storage times were achieved, and was intended to enhance the efficient 
use of a scarce resource, blood. Spinella and colleagues advocated for the use of whole 
blood transfusion after observing that transfusion of warm, fresh whole blood for 
treatment of hemorrhagic shock was associated with improved survival at both 24 hours 
(whole blood - 96%, components - 88%, p = 0.018) and 30 days (whole blood - 95% 
components - 82%, p = 0.002), when compared to those transfused with multiple blood 
components.(15) Improved survival with whole blood transfusion was attributed to lack 
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of anticoagulants and additives that are inherent to stored blood components.(15) 
Similarly, Nessen and colleagues found that infusion of fresh whole blood was an 
independent predictor of survival in those injured in combat (~ 90% reduction in 
likelihood of mortality), when compared with those who received multiple blood 
components, in spite of higher ISS, and lower admission blood pressure and core body 
temperature.(16)  
 Although management of hemorrhage focuses on control of blood loss and 
replacement of circulating volume, best practices related to transfusion have yet to be 
established. Thus, the aim of this study was to examine the association of type of blood 
transfusion, whole blood or blood components, with mortality in adult major trauma 
patients. We hypothesized that those who received whole blood would have a decreased 
likelihood of mortality compared to those who were transfused a combination of blood 
components in the management of their hemorrhage after trauma. 
Methods 
 We performed a secondary data analysis of the 2009 National Trauma Data Bank 
(NTDB) data set.(17) Five hundred sixty-seven facilities from across the United States 
voluntarily submitted data from all trauma patient admissions in 2008 to form the 
database (n = 627,664).(18) All data were de-identified prior to distribution of the data 
set.  
Sample 
We included those patients who were aged 18-45 years, had ISS greater than 25 
indicating critical injury, were admitted to the hospital after care in the ED, and who 
received blood transfusion, either whole blood or blood components, as part of their 
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emergency care. Patients were excluded from the analyses when they were dead on 
arrival to the emergency department, or were discharged to home after ED care and not 
admitted to the hospital.  
Measures 
Sociodemographic Variables   
Sociodemographic variables included in the analyses were age, gender, and 
ethnicity. Due to small numbers of minorities in the database, ethnicity was classified as 
Caucasian or other. Older age (> 55 years of age) is a risk factor for mortality in trauma 
victims because of pre-existing comorbidities, and decreased physiological response to 
injury.(19) Thus, we excluded those over age 45 years of age. We controlled gender in 
our analyses, as there is evidence to support gender differences in trauma survival and 
recovery, although this issue continues to be debated.(20-24) 
Injury Severity   
The ISS is a measure of trauma severity.(25) Scores are based on the extent of 
physiologic damage in the three most severely injured areas of the body (head/neck, face, 
chest, abdominal/pelvic, extremities/pelvic girdle, external) using the Abbreviated Injury 
Scale.(25) These scores are then squared and summed to achieve the ISS. Totals for the 
ISS range from to zero to 75, with higher scores indicating more severe injury. A typical 
cutpoint used in the literature to identify more severely injured patients is an ISS of 15 or 
greater, with a score of 25 indicating a critical state of injury.(26-30) The NTDB reports 
three versions of the ISS: the raw score reported by the hospital attending physicians, the 
score calculated in the database from the reported AIS scores, and the score that is 
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calculated from International Classification of Diseases, Ninth Revision (ICD-9) 
codes.(31)   
For this analysis, the ISS calculated from the ICD-9 codes was used as this was 
deemed the most valid for comparison purposes. The ISS is positively, although not 
linearly, correlated to mortality. Although higher ISS scores translate to higher likelihood 
of mortality for the trauma patient, given the scoring system of the ISS based on AIS 
scores, it is possible to have greater mortality rates for lower ISS scores (i.e. higher 
mortality for patients with an ISS of 16 versus 17) due to the physiologic location of the 
injury.(25, 32) The ISS has equivocal evidence to support the reliability and validity(33, 
34) of the measure, and there are few evaluations of the psychometric properties. 
However, this measure continues to be widely used in trauma practice, and it is an 
accepted standard for injury severity measurement.(32, 35)   
Emergency Medical System (EMS) Transfer Time   
EMS transfer time was defined as the time from dispatch of emergency medical 
services to the time the patient arrived at the ED measured in minutes. We controlled the 
EMS transfer time because there is evidence that prolonged time to definitive treatment is 
associated with greater blood loss, hypothermia, and acidosis, thereby increasing risk for 
mortality.(36)  
Transfer from Another Facility 
Patients were dichotomized into those admitted directly to the ED from EMS 
transfer and those transferred to a trauma center ED from another clinical facility. We 
controlled for this variables, as this may produce delay in definitive treatment.(37)  
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Blood Product Administration   
Blood products were categorized as administration of PRBCs and PLTs in 
combination, or whole blood transfusion (WBT). Data were not available for transfusion 
of fresh frozen plasma; thus, this component was not included in this analysis.  
Mortality   
Mortality was defined as death during the hospital stay for trauma, and was 
determined and reported by the attending physician. 
Statistical Analyses 
 Sample characteristics were analyzed using descriptive statistics, independent t-
tests and 𝜒2 as appropriate to describe the entire sample, and to compare those receiving 
blood components (PRBCs, PLTs, PRBCs/PLTs) with those who received whole blood, 
respectively. We used logistic regression to test the hypothesis that those transfused with 
whole blood would have a decreased likelihood of mortality compared to patients 
transfused with blood components after controlling for age, gender, and ISS. 
Demographic variables age, gender, and ISS were entered into the first regression block; 
EMS transfer time and transfer of the patient from another facility were entered into the 
second block. The blood product transfusion type, whole blood or components, was 
entered into the third block. An alpha level of 0.05 was set a priori to determine 
significance, and all analyses were performed using PASW, release 20.0 (SPSS, Inc., 
Chicago, IL). 
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Results 
Characteristics of the Participants 
 Participants (n = 1745) included in this analysis were primarily male (72%), 
Caucasians (63%), aged 29 + 8 years with an Injury Severity Score of 35 + 13 indicating 
critical injury (Table 1.).(26-29) Heart rate (HR) and systolic blood pressure (SBP) were 
available from both the EMS and emergency department records. Participants had a mean 
EMS HR of 99 + 26 and a mean emergency department HR of 101 + 26. Mean EMS SBP 
for the sample was 122 + 28, with a mean emergency department SBP of 127 + 30. The 
average EMS transfer time for these patients was 19 + 16 minutes, with a median time of 
14 minutes. Only 21% of patients were transferred from another facility. Twenty-six 
percent of these patients died during hospitalization for their traumatic injuries. Ninety-
five percent of participants received blood components (n = 1,662); only 5% received 
whole blood (n = 83); this demonstrated the ubiquitous nature of component transfusion.  
Those receiving whole blood and those receiving blood components were 
compared with independent t tests or 𝜒2 analyses based on the level of measurement 
(Table 1). Patients who received whole blood were 2 years younger than those who 
received components (whole blood - 27 ± 8 years, components - 29 ± 8 years, p = 0.01), 
and the proportion of females who received blood components was significantly greater 
than the proportion who received whole blood (components - 29%, whole blood -17%, p 
= 0.02). While a statistically significant difference in mean SBP was detected among the 
transfusion groups when measured in the emergency department, this difference was not 
clinically significant (whole blood – 112 + 29 mmHg, components – 120 + 32 mmHg, p 
= 0.036). There were no other differences between the groups.  
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Mortality Predictors 
We used logistic regression to determine independent predictors of mortality 
(Table 2). The model fit was evaluated using the Omnibus Tests of Model Coefficients 
and the Hosmer-Lemeshow test; these analyses determined that we identified a 
significant model (p < 0.001) with acceptable model fit (p = 0.318), respectively. Data 
were entered into the regression in blocks to control potential confounding variables and 
evaluate their relationship to mortality. 
The regression revealed three independent predictors of mortality: the ISS, EMS 
transfer time and type of transfusion, whole blood or components (Table 2). With each 
one-unit increase in ISS, patients were 14% more likely to die (OR 1.014, 95% CI 1.005 
– 1.024, p = 0.004), and for each minute increase in EMS time, patients experienced a 
1.2% decrease in likelihood of mortality (OR 0.987, 95% CI 0.975 – 0.999, p = 0.035). 
After controlling for age, gender, EMS transfer time and transfer from another facility, 
those patients who were transfused with blood components were 3.2 times more likely to 
die when compared with those who received whole blood (OR 3.164, 95% CI 1.314 – 
7.618, p = 0.010). Thus, our hypothesis was supported by the analysis.  
Discussion 
 We found that in this large sample of adult trauma patients, the type of 
transfusion, whole blood or blood component, was an independent predictor of mortality; 
those patients who received blood component transfusion were 3 times more likely to die 
when compared with those who received whole blood transfusion, even though ISS was 
identical. Other independent predictors of mortality were the ISS and the EMS transfer 
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time. Mortality risk increased 14% for each one unit increase in ISS, and decreased by 
1% for each additional minute of EMS transfer time.  
 Similar to our finding, other investigators have found that transfusion of whole 
blood produced superior survival compared to component transfusion. Combat patients 
who received whole blood had twice the likelihood of 30-day survival compared to those 
receiving blood components (OR 2.15, 95% CI 1.21-3.8, p = 0.016). Seghatchian and 
Samama concluded that fresh whole blood was superior to stored component transfusion 
with a 1:1:1 ratio (PRBCs:FFP:PLTs) in the prevention of coagulopathy in trauma 
patients, and Makley and colleagues found that transfusion of whole blood averted an 
inflammatory response produced by crystalloid resuscitation in animals after trauma.(38, 
39) In contrast, Ho and Leonard found no difference in 30-day mortality in patients who 
received whole blood compared with components for massive transfusion, defined as > 
10 units; however, only one fourth of these patients were treated for traumatic injuries, 
patients were older than ours (mean age 52 + 20 years), and diagnoses included 
gastrointestinal bleeding, cardiothoracic surgery and other types of surgery.(40) Thus, 
pre-existing comorbidities may have produced a confounding effect on mortality.     
 There is evidence that the age of blood components may have a significant effect 
on survival after transfusion. Current blood bank practices include the rotation of older 
PRBCs to trauma centers with high patient volume to reduce waste, as these centers are 
more likely to transfuse these components before they reach expiration and must be 
discarded.(41) Although the storage life of PRBCs is 42 days, there are predictable and 
identifiable morphological, biochemical, and functional alterations that occur and 
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produce a “storage lesion”; the older the age of stored components, the greater the 
changes. 
Morphological alterations found with storage lesion include change from the 
normal smooth, deformable disc-shape erythrocytes that easily bend to flow through the 
microcirculation, to a spheroechinocyte, a sphere-shaped cell with protrusions, which is 
rigid and more likely to adhere to the endothelium of the microcirculation.(42, 43) 
Release of submicron-sized fragments of the cellular membrane and hemoglobin, known 
as microparticles, is also a component of the storage lesion.(44) These microparticles 
stimulate inflammation, have procoagulant activity, and contain hemoglobin, which is a 
scavenger of nitric oxide, an endothelium-derived relaxing factor.   
Biochemical alterations found with the storage lesion are associated with 
continued cellular metabolism after donation, and include reduction in 2,3 
diphosphoglycerate (2,3 DPG),(45) which is important in the release of oxygen from the 
hemoglobin molecule, decreased cellular pH,(46) increased lactate (46) and intracellular 
potassium,(47) increased release of ubiquitin, an immune modulating protein,(48) and 
collection of lipids, cytokines and free iron released from hemolyzed cells.(46) The 
global consequences of the storage lesion after transfusion are rapid destruction of 
spheroechinocytes, reduced microcirculatory blood flow, altered coagulation, reduction 
in tissue oxygen delivery, ineffective endothelial vasoregulation,(45) impaired immune 
response, and systemic inflammation.  
There are also significant differences in 24-hour survival of erythrocytes after 
transfusion; packed cells stored for 25-35 days demonstrated double the degree of 
hemolysis when compared with those stored for less than 10 days (11% versus 22%, p < 
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0.05).(49) Unfortunately, we were unable to determine whether the storage lesion in the 
infused PRBCs was an independent predictor of mortality, as age of the transfused 
products was not available in the data set. This is an important focus for continued 
research.  
 We also found that the ISS was an independent predictor of mortality. This is not 
surprising, and provides additional evidence for the construct validity of the ISS. 
Numerous other investigators have also found the ISS to be a predictor not only for 
mortality, but also adverse outcomes and complications in the trauma population.(50-56) 
Dutton, Lefering, and Lynn found higher ISS to be predictive of both an increased risk 
for transfusion and an increased volume of transfused blood or blood components.(57) 
Similar findings were reported in a systematic review performed, indicating injury 
severity as an important predictor of the need for transfusion in the trauma 
population.(58) As those included in our analysis had the statistically same ISS, the need 
for transfusion should have been statistically equivalent based on this evidence.  
 The third independent predictor of mortality was the EMS transfer time with each 
additional minute of transfer time associated with a 1% decrease in mortality likelihood. 
The impact of transport time on the likelihood of mortality is equivocal, with data 
supporting increased and decreased likelihood, as well as no impact on mortality.  
Longer transport times are often associated with pre-hospital interventions. Recent 
evidence from the Prospective Observational Multicenter Massive Transfusion 
(PROMMT) group identified a 16% reduction in the likelihood of mortality in trauma 
patients who received intravenous fluid administration (59); Bernard and colleagues 
found that rapid sequence intubation in the pre-hospital setting was associated with 
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improved functional outcome in adults patients with severe traumatic brain injury.(60) 
Thus, pre-hospital interventions that require time have been shown to improve survival. 
We consider this to be a viable hypothesis for our finding.   
 In contrast, Gonzalez and colleagues found that longer EMS transport times were 
associated with higher mortality in rural trauma patients.(36) Johnson and colleagues 
identified a significant survival benefit in those trauma patients transported by private 
vehicle compared with EMS transport after controlling for ISS; thus, shorter transport 
time predicted greater likelihood of survival.(61) However, McCoy and colleagues found 
no association between transport time and mortality in nearly 20,000 patients with blunt 
and penetrating trauma(62), and The Resuscitation Outcomes Consortium Investigators 
also found no association between EMS activation time, on-scene, transport or total EMS 
time and mortality.(63) Thus, this variable is more complex than just the time in minutes 
and requires more systematic investigation, with consideration of the pre-hospital care 
administered.   
Our study was limited in several ways. First, the NTDB dataset provided 
retrospective data and contains limited variables for analysis. For example, transfusion of 
blood components or whole blood is available as a dichotomous yes-no variable, but 
quantification of the units of each component or units of whole blood transfused was not 
available. Furthermore, while EMS and ED heart rate and systolic blood pressure were 
available for analysis, these variables are not supported by prior research evidence as 
independent predictors of transfusion requirement or as adequate indicators of 
hemorrhage status; thus, they were not included in the regression.(64, 65) In addition, the 
validity of the data could not be evaluated and the accuracy of data entry is uncertain. 
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Errors in the database are possible because of the multiple hospitals, institutions, and data 
entry personnel who contributed to the database. We studied only a subset of younger 
patients in our analyses; thus, older patients may have different responses.  
Conclusion 
 We found that transfusion of whole blood rather than blood components produced 
superior survival in adult trauma patients from the NTDB. The inclusion of a 
geographically diverse sample increases the generalizability of our findings. The current 
practice of ubiquitous component administration in the trauma population requires further 
study to ensure that optimal trauma outcomes are achieved in those who receive 
transfusion. Our findings also support the construct validity of the ISS, a common 
instrument, used in clinical practice and research to quantify severity of injury. 
Unfortunately, our transport time finding adds to the ambiguity about mortality and pre-
hospital care, and demonstrates the need for further systematic evaluation of this complex 
issue.  
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Table 4.1 Characteristics of the Participants (n = 1745)  
 
Variable Total Sample 
n = 1745 
Whole blood 
n = 83 
Blood 
components 
n = 1662 
P 
value 
Age in years 29 + 8 27 + 8 29 + 8 0.01 
Gender Male 1253 (72%) 69 (83%) 1184 (71%) 0.02 
Ethnicity 
Caucasian 
 
1105 (63%) 
 
47 (57%) 
 
1058 (64%) 
 
0.20 
Injury Severity 
Score 
 
35 + 13 
 
39 + 17 
 
35 +13 
 
0.13 
EMS* Transfer 
Time in minutes 
 
19 + 16 
 
15 + 11 
 
19 + 16 
 
0.15 
Transferred from 
Other Facility 
(Yes) 
 
 
367 (21%) 
 
 
15 (18%) 
 
 
352 (21%) 
 
 
0.50 
Mortality  446 (26%) 17 (21%) 429 (26%)  0.27 
Values are mean + standard deviation or frequency (proportion) 
Groups compared using independent t tests for continuous variables and Chi square or Fishers Exact test 
for categorical variables 
* Emergency Medical Services 
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Table 4.2 Independent Predictors of Mortality In Adult Trauma Patients (n = 1745) 
 
Variable (Reference 
group) 
𝜷 Exp 𝜷 95% CI P 
value 
Age  -.009 .991 .975 – 1.008 0.32 
Gender (Male) -.274 .760 .554 – 1.044 0.09 
Injury Severity Score .014 1.014 1.005 – 1.024 0.004 
EMS* Time -.013 .987 .975 – 0.999 0.035 
Transfer (No) -.124 .883 .569 – 1.370 0.58 
Blood Product (Whole) 1.152 3.164 1.314 – 7.618 0.01 
Logistic regression analysis  
For categorical variables, comparison group in parentheses  
* Emergency Medical Services 
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Figure 4.1 Patient Mortality by Type of Transfusion 
 
Proportions compared with Chi Square analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0% 
5% 
10% 
15% 
20% 
25% 
30% 
Whole Blood Components 
M
or
ta
lit
y 
Pr
op
or
tio
n 
n = 1745 
p = 0.27 
	  	   92 
Figure 4.2 Mean ISS by Transfusion Type 
 
Scores compared using independent t tests 
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Figure Legend 
Figure 4.1 Patient Mortality by Type of Transfusion 
Figure 4.2 Mean ISS by Transfusion Type 
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CHAPTER FIVE 
 
Predictors of Inflammatory Complications in Patients Who Received Component 
Transfusion After Trauma 
 
Synopsis 
 
 Transfusion of blood components is associated with increased risk of in-hospital 
complications and mortality. Patients experience a decrease in physiologic reserve paired 
with release of anti-inflammatory and proinflammatory mediators following traumatic 
injury, making them subject to potential development of inflammatory complications. 
Findings from a secondary analysis of the Inflammation and Host Response to Injury 
Trauma-Related Database are presented (n = 1,656). Findings revealed that the total 
transfused volume of packed red blood cells in the first 24 hours following hospital 
admission was associated with development of inflammatory complications, as was the 
presence of comorbidities and injury severity. 
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Introduction 
 Five million individuals die from trauma annually worldwide according the World 
Health Organization;(1) traumatic hemorrhage accounts for 35% of pre-hospital deaths, 
and more than 40% of deaths within the first 24 hours after injury.(2) Trauma induces 
physiological mechanisms intended to halt blood loss. However, these mechanisms may 
be ineffective; continued bleeding will ultimately lead to hemorrhagic shock, “a failure of 
adequate tissue perfusion due to lack of circulating blood volume”.(3) A recent 
investigation demonstrated that hemorrhagic shock associated with trauma resulted in 
microcirculation alterations for up to 72 hours after restoration of adequate circulating 
volume, as a consequence of tissue hypoperfusion, inflammation, and resuscitation 
strategies.(4) These strategies included crystalloid infusion and transfusion of blood or 
blood components. However, blood transfusion volume and ratio of components in the 
transfusion (i.e. packed red blood cells [PRBCs] to fresh frozen plasma [FFP] to platelets 
[PLTs]) are independently associated with mortality;(5, 6) in fact, administration of blood 
components was associated with triple the likelihood of mortality compared with those 
who received whole blood (Odds ratio [OR} 3.164, Confidence interval [CI] 1.314 – 
7.618, p = 0.01) in civilian patients after trauma.(7) 
 There is a plethora of evidence to support an association between transfusion of 
blood components with an increased risk of complications (anywhere from a 37% (8) to 
over 3400%) (9) and mortality (ranging from 5% (10) to almost 80% (8)).(8-10) 
Although still controversial, some investigators concluded that there is a survival benefit 
when receiving blood components in a 1:1:1 ratio of PRBCs, FFP, and PLTs. This ratio is 
thought to mimic the composition of whole blood, which has been associated with 
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improved survival in high volume transfusion.(11-18) In addition, Kutcher and 
colleagues found that a reduction in volume of infused crystalloid, in conjunction with 
emulation of whole blood using a ratio of 1:1:1 for PRBCs, FFP and PLTs infusion, 
produced a 6% decrease in mortality for each reduction of 0.1 in the ratio.(19)    
 Current standard of practice for blood banks includes rotation of older stored 
components to trauma centers to reduce waste, as there are established storage times after 
which these components must be discarded.(20) However, stored components (PRBCs 
and PLTs) experience a storage lesion, which results in morphological, functional, and 
biochemical alterations of erythrocytes and platelets.(21, 22) The global consequences of 
the storage lesion are rapid destruction of abnormal erythrocytes known as 
spheroechinocytes, reduced microcirculatory blood flow, coagulopathy, reduction in 
tissue oxygen delivery, ineffective endothelial vasoregulation, impaired immune 
response, and systemic inflammation.(23-26)  
 The physiological response to traumatic injury includes the release of 
proinflammatory cytokines (e.g. tumor necrosis factor-∝ [TNF-∝], interleukin-6 [IL-6]) 
in reaction to injury to tissues, and anti-inflammatory cytokines to balance the 
proinflammatory cytokines, and return the body to a state of homeostasis.(27) The 
systemic inflammatory response to trauma is the result of damage-associated molecular 
patterns, which are secreted by activated immune cells that include neutrophils.(28) 
Cellular destruction and release of mitochondria and cellular peptides stimulate a 
particularly rigorous immune reaction, as they are interpreted to be foreign molecules.  
Current published theories propose that release of proinflammatory cytokines in 
the phase immediately following traumatic injury may be associated with detrimental 
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clinical outcomes.(28) In patients with severe traumatic injury, especially those receiving 
transfusions of blood or blood components, inflammation may become exacerbated and 
prolonged. Xiao and colleagues (29) examined leukocyte gene expression in patients 
following trauma, and found that expression was up-regulated for cytokines including IL-
6 and IL-10, and down-regulated for cytokines such as T cell regulators, beginning within 
12 hours of trauma and remaining throughout 28 days following injury.  
In the same study, investigators also compared genomic expression patterns of 
whole blood leukocytes for patients who experienced a complicated (development of 
organ failure and/or infection in addition to recovery > 14 days, no recovery, or death) 
versus uncomplicated (recovery < 5 days) recovery.(29) Their findings revealed that 
patients with an uncomplicated recovery experienced a return to baseline in their 
leukocyte gene expression within 2 weeks of injury; in patients with complicated and/or 
prolonged recovery, early leukocyte gene expression changes were greater, and changes 
observed immediately following injury had not returned to baseline by 28 days post-
injury. Thus, genomic expression and release of proinflammatory and anti-inflammatory 
cytokines occurs in the first 24 hours post-injury, and increased expression is prolonged 
in those with more complicated recovery, including the development of inflammatory 
complications during hospitalization (e.g. acute respiratory distress syndrome, acute renal 
failure, nosocomial infections, surgical site infections, sepsis, and ventilator-associated 
pneumonia).   
Infection after trauma is common. Investigators found that 52% of trauma patients 
developed an infection while in critical care; those who presented to the emergency 
department (ED) with shock (defined using base deficit > 12 mEq/L) developed 
	  	   98 
infectious complications more rapidly compared to those with hemodynamic stability 
(median 3.5 days versus 5 days, p = 0.01).(30) Other investigators found infectious 
complications were associated with a prolonged length of stay in patients after trauma, 
ranging from a median of 13 days for urinary tract infection/acute cystitis (Interquartile 
Range [IQR] 7-24 days) to a median of 27 days for both sepsis (IQR 17-41) and surgical 
infections (IQR 17-41).(31) These same investigators found a significant increase in the 
relative risk for mortality associated with complications, including cardiovascular events 
(33%), renal failure (24%), ARDS (16%), and sepsis (13%) (p < 0.05).(31) Recently, 
median hospital charges for patients after trauma with an infectious or incisional 
complication were 70% greater than the costs for those without these complications (with 
infection - median $171,376 (IQR $83,980 – $310,104); without infection - median 
$50,980 ($26,398 – $94,631), (p < 0.001).(32)  
 Thus, inflammatory and infectious complications increased not only patient length 
of stay and likelihood of mortality, but also costs for both patient and hospital. 
Furthermore, transfusion of blood components is associated with additional inflammatory 
activation and increased complications and mortality.(9, 33) Therefore, the purpose of 
this study was to evaluate the relationship of transfusion-related variables (volume and 
ratio of transfused components) to development of inflammatory complications in trauma 
patients.  
The aims of this study were: 1) to evaluate the prevalence of inflammatory 
complications (organ failure, nosocomial infections, Acute Respiratory Distress 
Syndrome [ARDS], pneumonia, central line associated blood stream infection [CLABSI], 
urinary tract infection [UTI], sepsis or septic shock) developed during hospitalization in 
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an adult major trauma population; 2) to determine whether blood transfusion volume and 
ratio of components transfused within the first 24 hours following admission to the ED 
predicted development of inflammatory complications during hospitalization; 3) to 
determine whether blood transfusion volume and ratio of components transfused within 
the first 24 hours following admission to the ED predicted time to diagnosis of 
inflammatory complications; 4) to determine whether inflammatory markers measured 
within the first 24 hours following admission to the ED and receipt of blood transfusion 
predicted development of inflammatory complications during hospitalization. 
Methods 
 We performed a secondary analysis using the Inflammation and Host Response to 
Injury Glue Grant trauma database (TRDB).(34) The data available through the TRDB 
contained de-identified human data prospectively collected from eight Level I trauma 
institutions across the United States. This dataset included data from over 1,600 patients 
after blunt trauma hospitalization (up to 28 days), who were enrolled between 2003 to 
2009. Vital signs available for analysis included temperature, heart rate, mean arterial 
pressure, and respiratory rate. The values were recorded as the highest and lowest values 
in association with calculation of the Acute Physiology and Chronic Health Evaluation 
(APACHE) II score, which is based on assessment of vital signs and laboratory values in 
the first 24 hours of hospitalization. This instrument is used to quantify severity of illness 
in critical patients, and to estimate requirements for hospital resources, determine nursing 
staffing patterns, and predict mortality.(35) As the NISS is a more widely accepted and 
used instrument for categorizing trauma patients, APACHE II scores were not included in 
the analysis.  
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Transfusion data were recorded at 6-hour intervals beginning from the time of ED 
admission. Pre-hospital crystalloids and blood volume received prior to patient admission 
to a tertiary care center were collected as well. Demographic variables age, sex, and 
ethnicity were collected on patient admission to the ED. The New Injury Severity Score 
was computed after the patient was admitted to the hospital, and was based on injuries the 
patient sustained.(36) 
Sample and setting 
 We included patients between 18 and 65 years of age, who received transfusion of 
blood components within the first 24 hours following injury, and with an Injury Severity 
Score (ISS) of > 15, which indicated severe injury. We excluded participants above the 
age of 65 due to likelihood of multiple comorbidities, and decreased physiologic reserve 
that may have limited survival.(37) Participants were also excluded if they died within 
the 24 hours following admission to reduce survival bias. A small subset of patients was 
recruited by the TRDB investigators for evaluation of inflammatory biomarkers 
following admission in addition to collection of other clinical variables.  
We determined that a logistic regression would have at least 80% power to detect 
an odds ratio of 1.5 when the sample size was 250, with the assumption that the rate of 
complications at the mean of the explanatory variable was 50%, and that there was 
moderate correlation among the variables included in the model. After exclusion criteria 
were applied, our sample included 1,656 patients. We then further selected those who 
received transfusion of all three major components (PRBCs, PLTs, and FFP) in the first 
24 hours. 
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 All data were collected from Level I civilian trauma centers. The Level I 
designation is a reflection of the verification provided by the American College of 
Surgeons that denoted the ability of a facility to provide appropriate care for the most 
severely injured patients around the clock.(38, 39) Level I facilities typically serve large 
cities or metropolitan areas, and may provide higher level services to smaller hospitals in 
the surrounding areas as well, with provision for the transfer of critically injured patients 
to a higher level of care when necessary.(39) 
Measures 
Sociodemographic Variables 
Sociodemographic variables included in our analyses were age, sex, and ethnicity. 
Ethnicity was classified as Caucasian, African American, or other, due to small numbers 
of minorities other than African American. Data related to the hospital location consisted 
of de-identified site codes, thus limiting our ability to specify the region of the country in 
which the patient was treated. No information was available regarding education, pre-
existing health conditions, insurance status, socioeconomic status, or employment.  
Clinical Variables  
 Twenty-eight day survival was recorded as a dichotomous yes/no variable. 
Hospital length of stay in days was also recorded as full days. For those who survived 
beyond 28-days, the total hospital length of stay was documented. Vital signs were 
analyzed highest and lowest as recorded during the first 24 hours of hospitalization. 
Temperature was originally recorded in degrees Celsius then converted into degrees 
Fahrenheit. Glasgow Coma Score (GCS) total values were recorded in two ways, as the 
worst GCS experienced during the first 24 hours of hospitalization, and GCS while in the 
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ED. Laboratory values were also available to characterize the sample. Values recorded as 
part of the APACHE II data included hematocrit and arterial pH, again recorded as the 
highest and lowest values. Other laboratory values measured while the patient was in the 
ED were serum lactate, hemoglobin, international normalized ratio (INR), and base 
deficit. The volume of crystalloids infused prior to admission to the ED was also 
recorded and measured in milliliters (mL). 
Injury-Related Variables 
 Mechanism. Mechanism of injury was originally categorized as one of the 
following: fall, machinery, motor vehicle collision (MVC) – occupant, MVC – 
motorcyclist, MVC – cyclist, MVC – pedestrian, struck by or against, or other. Due to 
small numbers of those in categories of falls, machinery accidents, cyclists, pedestrian, 
and struck by or against, these patients were then grouped in the other category. 
Injury Severity Score. The Injury Severity Score (ISS) is based on the 
Abbreviated Injury Scale (AIS), an instrument used to assign scores to the areas of the 
body most affected by injury.(40) The AIS is an ordinal scale with values assigned to 
each area of the body based on the most severe injury to that area; values ranged from 0 
indicating no injury, to 6 indicating a fatal injury.(40, 41) The ISS is calculated by taking 
the three areas of the body most severely injured according to corresponding high AIS 
scores, squaring them, and summing them. ISS values range from 0 to 75, with higher 
numbers indicating more severe injury. Evidence supporting the reliability and validity of 
the ISS is equivocal.(42) Nonetheless, the ISS is commonly used in trauma centers and 
research studies to quantify the extent of physiologic injury.(43) 
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 The version of the ISS found in the TRDB, the New ISS (NISS),was a modified 
version of the original instrument. The NISS was released in 1997, and has been shown 
to be a better predictor of mortality compared with the ISS.(36) The NISS uses the same 
range of scores as the original ISS, but the instrument evaluates the three most severe 
injuries sustained by the patient, regardless of the area of the body in which the injuries 
are found.(36) For our study, we included patients with a NISS score of 15 or higher, a 
cut point commonly used in trauma research to distinguish those with severe and critical 
injuries.(44-46) For analysis of specific aims 2-3, NISS was transformed into a 
dichotomous variable, with a score of > 25 indicating severe/critical injury, and a score of ≤ 24 indicating mild/moderate injury. 
Comorbid Burden  
 Comorbidities were indicated in the database with yes/no responses for each 
specific comorbid condition. Total number of comorbidities was calculated by summing 
the number of affirmative responses. Values ranged from 0 – 33. Comorbidities evaluated 
by the investigators included: hypertension which required medications, myocardial 
infarction, congestive heart failure, atrial and ventricular tachyarrhythmias, peripheral 
vascular disease, cerebrovascular disease, dementia, seizure disorder, previous traumatic 
brain injury, hemi- or paraplegia, Parkinson’s disease, chronic obstructive pulmonary 
disease, rheumatologic disease, peptic ulcer disease, liver disease, diabetes, hypo- or 
hyperthyroidism, chronic renal dysfunction, history of malignancy, metastatic solid 
tumor, human immunodeficiency virus, acquired immunodeficiency syndrome, 
congenital or acquired coagulopathy, smoking, chronic alcoholism, intravenous drug use, 
homelessness, psychiatric disorder, solid organ transplant recipient, and chemotherapy or 
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radiation therapy in the last 30 days. Patients were dichotomized into those who had at 
least one comorbidity versus those who had none. With this variable, we controlled for 
comorbid burden in the analyses, as more complications and reduced survival are 
associated with a greater comorbid burden.(47)  
Transfusion-Related Variables 
 Total volume of blood components transfused included the total number of mL 
transfused in the first 24 hours after trauma. Total volume of PRBCs, FFP, and PLTs 
were available for analysis. PRBC volume was converted from mL to units based on the 
assumption that the average volume per unit of PRBCs is 300 mL.(48) FFP volume was 
converted to units using an average unit volume of 200 mL,(49) and PLT volume was 
converted based on an average volume of 50 mL.(50) Ratios of components were 
separated into the ratio of PRBC:FFP and PRBC:PLT, again calculated based on 
transfusion volume in the first 24 hours after admission, and presented in decimal 
notation (instead of 3:4, recorded as 0.75 or 0.8). For logistic regression and time-
dependent analysis, the transformed ratio values were categorized as those between 0.5-
1.5 and those outside of that range. We performed this transformation to determine the 
impact of the ratio moving away from 1:1 (absolute value of 1.0), as evidence exists to 
support a ratio of 1:1 as beneficial to survival and development of complications for 
trauma patients receiving component transfusion.(51) 
Inflammation   
Complications 
 Complications chosen for analysis included organ failure, ventilator-associated 
pneumonia (VAP), sepsis or bloodstream infection, catheter-related bloodstream 
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infection (CRBSI), urinary tract infection (UTI), acute respiratory distress syndrome 
(ARDS), and nosocomial infections (NIs). NIs included non-ventilator associated 
pneumonia, meningitis, sinusitis, endocarditis, acute cholecystitis, empyema, and 
pseudomembranous colitis. Diagnosis was based on pre-established criteria developed by 
the Glue Grant investigators.(52) Organ failure was based on the Denver score,(53, 54) 
where a total score of three or more indicated multiple organ failure. A score of one 
indicated presence of organ failure (pulmonary, cardiac, renal, or hepatic), but specific 
information pertaining to the failing organ was not available; thus, patients with a score 
of one or more were determined to have organ failure and were compared to those with a 
score of zero (no organ failure). Development of any inflammatory complications during 
hospitalization was categorized as a dichotomous variable in the dataset. Patients were 
considered to have developed inflammatory complications if at least one of the 
complications was diagnosed. Total number of complications was also calculated for 
those complications included in the analysis; values ranged from 0-7. Time to 
development of complication was calculated in the database as time from injury to time 
of diagnosis of a complication, measured in days. For patients with more than one 
complication during hospitalization, we used the time to first diagnosed complication.  
Statistical Analyses 
 Initial Kolmogorov-Smirnov tests were used to determine the distribution of the 
data. Descriptive statistics including frequencies and percentages, medians (IQR), and 
means (standard deviations) were used to characterize the participants. Correlations of 
variables were evaluated to determine the presence of collinearity prior to logistic and 
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Cox regressions. An 𝛼 of .05 was set a priori to determine significance. All analyses were 
performed using PASW, release 22.0 (SPSS, Inc., Chicago, Illinois). 
Specific aim 1 was to evaluate the prevalence of inflammatory complications 
(organ failure, NI, ARDS, VAP, CLABSI, UTI, or sepsis) developed during 
hospitalization in an adult major trauma population. Frequencies were used to analyze the 
prevalence of these outcomes among patients.  
The second aim was to determine whether blood transfusion volume and ratio of 
components transfused within the first 24 hours following admission to the ED predicted 
development of inflammatory complications during hospitalization. We used a logistic 
regression with the dichotomous variable created to indicate those who developed a 
complication and those who did not. Age, gender, and presence of at least one 
comorbidity were entered into the first block; NISS (categorical) was entered into the 
second block, followed by transfusion variables in the third block (24-hour total units of 
PRBCs, 24-hour total units of PLTs, PRBC:PLT ratio [categorical], and PRBC:FFP ratio 
[categorical). The 24-hour FFP total units were not included in the model, as this 
component does not develop the storage lesion. Investigators have suggested a protective 
mechanism women compared to men who have traumatic injury; thus, we controlled for 
gender in our analyses.(55-57) 
To determine whether blood transfusion volume and ratio of components 
transfused within the first 24 hours following admission to the ED predicted time to 
diagnosis of inflammatory complications, a Cox proportional hazards model was used. 
Kaplan-Meier analysis and log-rank testing were used to compare time to complication 
for patients based on their ratio of PRBC:PLT units (0.5-1.5 versus other) and PRBC:FFP 
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units (0.5-1.5 versus other). For the Cox model, age, gender, and presence of at least one 
comorbidity were entered into the first block; NISS (categorical) was entered into the 
second block, followed by transfusion variables in the third block (24-hour total units of 
PRBCs, 24-hour total units of PLTs, PRBC:PLT ratio [categorical] and PRBC:FFP ratio 
[categorical]). The 24-hour FFP total units variable was again not included in the model. 
The final aim was to determine whether inflammatory markers measured within 
the first 24 hours following admission to the ED and receipt of blood transfusion predict 
development of inflammatory complications during hospitalization. Due to the small 
number of patients with values available for the biomarkers (n = 17), these analyses were 
not performed.  
Results 
Characteristics of the Participants 
A total of 1,538 patients were included in these analyses (Table 1.). The majority 
were Caucasian (90%), males (68%), with an average age of 39 ± 14. Patients had an 
average of 1 ± 1 comorbidity; one-third of patients had two or more comorbidities, and 
39% had none. The three most commonly reported comorbidities were smoking (30%), 
chronic alcoholism (14%), and psychiatric disorders (11%). Patients were critically 
injured, with a median NISS of 39 ± 13; 70% were involved in a MVC as either an 
occupant of the vehicle, or as a motorcyclist. Approximately a quarter of patients (28%) 
were transferred from another hospital, with a 90% 28-day survival rate. GCS on 
admission to the ED was 8 ± 6; worst GCS recorded in the first 24 hours was 5 ± 4, 
which indicated significant loss of consciousness and cognitive impairment. 
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The lowest body temperature measured in the first 24 hours was an average of 
95.0 ± 2.3 °F, whereas the average highest temperature in the first 24 hours was 100.4 ± 
1.4 °F. Mean arterial pressure ranged from an average low of 52 ± 17 mmHg to an 
average high of 118 ± 19 mmHg in the first 24 hours of care. Heart rates were elevated, 
with an average low of 77± 21 beats/minute (bpm), and an average high of 137 ± 21 
bpm. The average low pH for patients in the first 24 hours was 7.2 ± 0.1, with a mean 
first base deficit of -8.8 ± 4.4; the average high pH during the first 24 hours was 7.4 ± 
0.1. On admission to the ED, the first median hemoglobin was 11.6 ± 2.6 grams/deciliter 
(g/dL), and the first mean INR was 1.4 ± 0.7. In addition, patients had an average low 
hematocrit of 24 ± 6% and a high of 39 ± 5%. 
Prior to ED admission, patients received an average of 219 ± 592 mL of blood 
(not further specified) and a mean of 2,178 ± 2,236 mL of crystalloid. In the first 6 hours, 
92% of these patients received PRBCs, 50% received FFP, and 26% received PLTs 
(Table 2.). By the end of the first 24 hours, all patients had received PRBCs, whereas 
65% received FFP, and 40% received PLTs. Average volume of PRBCs transfused in the 
first 6 hours was 1,977 ± 2,329 mL or 6.6 ± 7.8 units. FFP infusion was an average of 
705 ± 1,102 mL or 3.5 ± 5.5 units, with an average volume of PLTs infusion of 125 ± 
330 mL or 2.5 ± 6.6 units. Ratio of PRBC:FFP units at 6 hours were a mean of 1.9 ± 1.9, 
meaning that patients received 1.9 units of PRBCs per unit of FFP. Mean PRBC:PLT 
ratio at 6 hours was 1.9 ± 2.1, which indicated that patients received nearly 2 units of 
PRBC per unit of PLTs. At 24 hours after admission, an average of 2,843 ± 3,599 mL 
PRBCs or 9.5 ± 12.0 units were transfused. Total FFP administered by 24-hours after 
admission equaled 1,195 ± 1,899 mL or 6.0 ± 9.5 units, and 242 ± 486 mL of PLTs or 
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2.5 ± 6.6 units were administered. Ratio of blood components for PRBC:FFP at the end 
of the first 24-hour period following admission were a mean of 1.9 ± 2.0 units. This 
indicated that patients received about 2 units of PRBC per unit of FFP. Mean ratio of 
PRBC:PLT was 2.6 ± 2.9. In other words, patients received about 2.5 units of PRBCs for 
each 1 unit of PLTs. A total of 376 patients received all three components at the end of 
the first 24-hour period following admission. 
Thirty-two percent of patients were discharged home with or without services; 
almost one third of patients (27%) were sent to an inpatient rehabilitation facility, and 
another 24% went to a skilled nursing facility. Of those who died (10% 28-day 
mortality), major cause of death included brain death (25%) and multiple organ failure 
(19%). 
Prevalence of Complications 
Eighty-six percent of the sample developed at least one of the specified 
inflammatory complications (organ failure, VAP, CRBSI, UTI, sepsis, ARDS, or NI) 
(Table 3.). For those with organ failure, 76% had a score of one or greater and 36% 
developed multiple organ failure. Almost a third of patients developed VAP (27%). Only 
3% of patients developed a CRBSI. Fourteen percent of patients developed a UTI, and 
13% developed sepsis. Approximately a quarter of patients (24%) were diagnosed with 
ARDS. Almost half of the patients developed a nosocomial infection (45%). Time to 
diagnosis of first complication was a median of 5 days (IQR 2 – 8).  
Inflammatory Complications Predictors 
Logistic regression was used to determine independent predictors of inflammatory 
complication (Table 4.). Variables were entered by blocks to control for confounding and 
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determine relationships with development of inflammatory complications. Age, gender, 
and presence of at least one comorbidity were entered first, followed by NISS 
(categorical) and transfusion variables (24-hour total units of PRBCs, 24-hour total units 
of PLTs, PRBC:PLT ratio [categorical], and PRBC:FFP ratio [categorical). The Omnibus 
tests of model coefficients and the Hosmer-Lemeshow test were used to determine model 
fit; we developed a significant model (p < 0.001) with acceptable model fit (p = 0.241). 
We found two independent predictors of development of inflammatory complications, 
presence of comorbidities and the 24-hr total of PRBC units transfused. The presence of 
at least one comorbidity was associated with a 5-fold risk in development of 
inflammatory complications (OR 5.367, 95% CI 2.235-12.886, p < 0.001). With each 
additional unit of PRBCs transfused, risk of developing an inflammatory complication 
increased by 8% (OR 1.083, 95% CI 1.018 – 1.151, p = 0.011). Patient age was found to 
be protective for development of inflammatory complications, but was not statistically 
significant at the 0.05 level (p = 0.053). 
Time to Complication Development 
Cox proportional hazards model was used to determine predictors of time to 
development of inflammatory complications (Table 5.). Variables were entered into the 
model based on their potential for confounding and to evaluate their relationship with 
timing to development of inflammatory complications. Age, gender, and presence of at 
least one comorbidity were entered first, followed by NISS (categorical) and transfusion 
variables (24-hour total units of PRBCs, 24-hour total units of PLTs, PRBC:PLT ratio 
[categorical], and PRBC:FFP ratio [categorical). The Omnibus tests of model coefficients 
indicated that a significant model was identified (p < 0.001). Results of the Cox 
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regression revealed two independent predictors of time to complication development, 
NISS and 24-hr total PRBC units transfused. Those with severe or critical injury severity 
(NISS ≥ 25) experienced a 41% increase in the likelihood of developing an inflammatory 
complication compared to those with mild/moderate injury (NISS ≤ 24) (hazard ratio 
[HR] 1.409, 95% CI 1.034 – 1.920, p = 0.03). For each additional unit of PRBCs 
transfused, patients experienced a 1% increase in their likelihood of developing an 
inflammatory complication (HR 1.010, 95% CI 1.04 – 1.016, p = 0.001). A 20% increase 
in the risk of inflammatory complications was observed for those with male gender, but 
this was not statistically significant at the 0.05 level (p = 0.053). 
Log-rank testing did not reveal any significant differences between either 
PRBC:FFP ratio groups or PRBC:PLT ratio groups in terms of time to development of 
complications (Figure 1.,2.). Median time to development of complications for the 24-hr 
PRBC:FFP ratio groups was 7 days for both ratio groups (p = 0.709). Median time to 
development of complications for those who received a 24-hr PRBCs:PLTs ratio between 
0.5-1.5 was 8 days, compared to 6 days for those who were outside of this range (p = 
0.282). 
Discussion 
 A majority of patients transfused after traumatic injury (86%) developed at least 
one inflammatory complication during their hospitalization. Independent predictors of 
inflammatory complication were the presence of at least one comorbidity and the 24-hour 
total transfused volume of PRBC units. The 24-hour total of PRBCs transfused was also 
an independent predictor of time to development of inflammatory complications, as was 
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critical or severe injury as indicated by a NISS of 25 or more. Other transfusion-related 
variables were not predictive of time to complication development.  
 The 24-hr transfusion volume of PRBCs was an independent predictor of 
inflammatory complication development; thus the storage lesion in PRBCs must be 
considered as a potential mechanism. These effects include the eventual transition of cells 
to anaerobic metabolism and depletion of adenosinetriphosphate (ATP), a decrease in pH 
from lactic acid production and cellular edema with possible rupture due to failure of the 
ATP sodium-potassium pump within the cell membrane.(21) When cells experience a 
breakdown in membrane structure, the contents of the cell leak into the supernatant, or 
the preservative fluid. These contents include electrolytes, microparticles or pieces of 
phospholipid membrane, and proinflammatory mediators that circulate freely in the 
stored component.  
The storage lesion worsens over time. The practice of transfusion of older stored 
components to patients with major trauma could result in worse outcomes.(20) However, 
data about the relationship between age of transfused PRBCs and adverse outcomes are 
equivocal.(58) Investigators suggested that patients who were injured severely enough to 
require transfusion of multiple units of PRBCs for resuscitation could experience 
exacerbated vasoconstriction after transfusion.(33) Thus, transfusion of older components 
would reduce circulation to tissues and lead to development of complications.(59) Others 
have suggested that over-transfusion of patients, or overloading them with components in 
order to restore circulating volume, resulted in worse outcomes, which would support our 
findings here.(33) Though the mechanisms that produced inflammatory complications 
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after trauma are not clear, our findings support this association. This requires further 
investigation.(8, 9)  
The ratio of transfused components was not a predictor of inflammatory 
complications in this study. There is evidence to support transfusion of components in a 
1:1:1 fashion for patients with major trauma who required 10 or more units of PRBCs in 
the first 24 hours.(60, 61) However, the optimal ratio for patients who require less 
transfused components has not been determined. Differences among patients and 
transfusion requirements may originate with the state of coagulation, where 
exsanguinating patients require more clotting factors through transfusion of FFP and 
PLTs compared to less severely injured patients.  
The association between transfusion and inflammation in our patients supports the 
findings of other investigators. Cole and colleagues (30) analyzed a sample of 271 
severely injured trauma patients (median ISS 29, IQR 21-36) with a median age of 35 
(IQR 25-49) to determine rate of infection following critical care admission. These 
investigators found an overall an infection rate of 52%; those who developed infection 
received significantly greater volume of PRBCs in the first 24 hours of hospital care than 
those who did not develop an infection (median units 4, IQR 3.4-5.4, versus 3, IQR 2.1-
3.7, p = 0.01). However, volume of PRBCs was not an independent predictor of infection 
in their analysis. These investigators also found a lower rate of infections than in our 
participants. This finding may be due to their smaller sample size or younger median age. 
Also, the investigators did not report the frequency of blood component transfusion 
among their sample, so it is possible that not all participants received transfusions, which 
could impact development of complications. 
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 Other investigators evaluated the relationship between coagulopathy following 
trauma and development of infection during hospitalization.(62) They found that less 
than half of their sample developed an infection (45%). Of those who developed an 
infection, patients were older (median age 44 years, IQR 25-59 versus 32 years, IQR 24-
42, p = 0.02) and more severely injured (median ISS 25, IQR 15-33 versus 10, IQR 5-18, 
p < 0.01) than those without infection. However, the investigators did not find any 
differences in coagulation between those who developed infection and those who did not, 
which supports the notion that the physical transfusion of components rather than the 
physiological need for transfusion based on presence of coagulopathy may be more 
intricately related to development of inflammatory complications.  
 The inflammatory response following trauma, in conjunction with transfusion of 
stored components with the storage lesion may play a role in the development of 
complications. One effect of the storage lesion is the leaking of intracellular contents 
including proinflammatory mediators into the supernatant or preservative fluid after 
breakdown in the phospholipid membrane. Transfusion of components containing 
extracellular proinflammatory mediators contributes to an inflammatory response in 
patients. Evidence exists to support an increase in in vivo proinflammatory mediators 
following injury as well, while suppression of genes that stimulate an anti-inflammatory 
response also occurs.(29) Imbalances in inflammatory cytokines can last for weeks, 
creating an opportunity for patients to succumb to inflammatory complications. 
 We found that the presence of at least one comorbid condition was independently 
associated with development of inflammatory complications. Smoking was the most 
frequently reported comorbidity. Bell, Bayt, and Zarzaur found no association between 
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smokers and complications after traumatic injury (smoker prevalence 9.7% versus 
nonsmoker prevalence 9.6%, p = 0.763).(63) Ferro and colleagues supported this finding 
with similar rates of sepsis, pneumonia, ARDS, and MODS among smokers and non-
smokers.(64) However, numerous prior investigations have clearly implicated cigarette 
smoking with up-regulation of proinflammatory cytokines and down-regulation of anti-
inflammatory cytokines. Prior investigators suggested that cigarette smoking was 
associated with prolonged bone healing after fracture, and the risk for nonunion of 
fracture and wound infection.(65) However, recent investigators found that after trauma 
cigarette smokers were 85% less likely to die and 27% less likely to develop a major 
complication compared with nonsmokers.(63) Thus, evidence about an association 
between smoking and inflammatory complications after trauma is equivocal and the 
proposed protective mechanism requires further investigation.(66-69)   
Cigarette smoking is often associated with chronic alcoholism and psychiatric 
disorders,(70) two common comorbidities of our participants. Yaghoubian and colleagues 
(71) found that a positive blood alcohol on admission after trauma was not associated 
with complications. Similarly, Zeckey and colleagues (72) reported that alcohol 
consumption was not an independent predictor of sepsis or systemic inflammatory 
response syndrome in patients after trauma.	  However, alcohol intoxication has been 
demonstrated to produce dysregulation of immune mechanisms after trauma with 
consequent suppression of proinflammatory cytokine release, reduced neutrophil 
recruitment, decreased phagocytosis, impaired chemotaxis, and suppressed oxidative 
burst capacity;(73) thus, the likelihood of infection is augmented. Individuals with 
chronic and acute alcohol intoxication who have peripheral vascular injury were 
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demonstrated to require more surgical interventions, have more infections, vascular 
complications, and longer hospital stays compared with those not exposed to alcohol.(74) 
Ray and colleagues found that alcohol use was predictive of poorer outcomes after hip 
fracture; deep tissue infection and mortality rate 26 times higher than non-alcohol users 
were evident.(75) Crutcher and colleagues found that alcohol use increased the risk for 
multiple complications that included pneumonia, pulmonary embolus, and urinary tract 
infection in individuals after spinal cord injury.(76) Thus, alcohol, trauma, and 
transfusion may increase the likelihood of greater morbidity and mortality.  
Injury severity was the final predictor of complications. Injury provided 
opportunity for complications through breaks in skin integrity, and the release of anti- 
and proinflammatory mediators,(29) as well as placement of invasive catheters, and 
exposure to multiple organisms found in the environment at the site of injury and the 
hospital during treatment. The NISS has been a significant predictor of both sepsis (OR 
1.11, 95% CI 1.04-1.19, p = 0.0028) and severe systemic inflammatory response 
syndrome (OR 1.07, 95% CI 1.00-1.14, p = 0.04) in adult patients with major trauma.(77) 
In addition, the NISS has been associated with complicated recovery and development of 
MOF, where patients with uncomplicated recovery and no MOF were less injured 
compared to those who developed MOF (average NISS 32.6 ± 1.8 versus 39.8 ± 1.9, p = 
0.01).(78) Therefore, our results support the construct validity of the NISS, and coincide 
with those in the existing trauma literature.(77, 79, 80) 
Limitations 
 The findings of our study should be considered in light of several limitations. 
First, the data provided through the TRDB were limited in that the investigators selected 
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the variables for data collection, thereby restricting our selection for analysis. One 
variable of particular interest that was not available in this database was the age of the 
transfused components. Other variables that would have supplemented our study are 
timing of component transfusion in relation to time of injury and levels of inflammatory 
cytokines for all patients. Though a small subset of patients had data available for 
cytokines, these data were inadequate for our analyses.   
 Second, because the data were deidentified prior to release for secondary analysis, 
the validity could not be determined. Data entry by multiple personnel at each location 
lends itself to the possibility of errors. Finally, we restricted our analysis to patients 
between the ages of 18-65 to reduce the potential influence that older age and more 
comorbid conditions might introduce. However, our participants exhibited a number of 
comorbid conditions.  
Conclusion 
 A majority of our participants with major trauma developed inflammatory 
complications during their hospitalization. The volume of PRBCs transfused in the first 
24 hours of hospitalization and the presence of comorbid conditions were independently 
associated with the development of complications. Although the likelihood that comorbid 
conditions are associated with complication has been previously hypothesized, clinicians 
often do not have access to these data at the time of management. The severity of injury 
was also a predictor of inflammatory complications. Enhanced understanding of the 
mechanisms that contribute to immune alterations after trauma and transfusion may 
provide clinicians with the ability to individualize patient management and monitoring 
for complications to produce improved outcomes.    
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Table 5.1 Characteristics of the Sample (N = 1,538) 
Characteristic Mean (SD) or n (%) 
Sex (male) 1,040 (68%) 
Age (y) 39 ± 14 
Ethnicity  
     Caucasian 1,364 (89%) 
     African American 99 (7%) 
     Other* 67 (4%) 
Number of Comorbidities  
     0 598 (39%) 
     1 452 (29%) 
     2 or more 488 (32%) 
Commonly Reported Comorbidities  
     Smoking 457 (30%) 
     Chronic alcoholism 212 (14%) 
     Psychiatric disorder 170 (11%) 
New Injury Severity Score  39 ± 13 
Mechanism of Blunt Injury  
     MVC - occupant  818 (53%) 
     MVC - motorcyclist 267 (17%) 
     Other** 453 (30%) 
Pre-Hospital Blood (mL) 219 ± 592 
Pre-Hospital Crystalloids (mL) 2,178 ± 2,236 
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Table 5.1, Cont. 
 
Temperature (°F)  
      Low 95.0 ± 2.3 
      High 100.4 ± 1.4 
MAP (mmHg)  
      Low 52 ± 17 
      High 118 ± 19 
Heart Rate (bpm)  
      Low 77 ± 21 
      High 137 ± 21 
Respiratory Rate (breaths/min)  
      Low 12 ± 4 
      High 27 ± 7 
pH  
      Low 7.2 ± .1 
      High 7.4 ± .1 
Hematocrit (%)  
      Low 24 ± 6 
      High 39 ± 5 
Hemoglobin (g/dL) 11.6 ± 2.6 
INR  1.4 ± .7 
Base Deficit -8.8 ± 4.4 
ED GCS 8 ± 6 
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Table 5.1, Cont. 
 
APACHE II GCS 5 ± 4 
Transfer From Another Hospital (yes) 433 (28%) 
28-Day Patient Survival  1,387 (90%) 
Primary Cause of Death  
     Brain death 37 (25%) 
     Multiple organ failure 28 (19%) 
     Other*** 86 (57%) 
Non-Infectious Complications (yes) 655 (43%) 
Number of Inflammatory Complications 2 ± 2 
Disposition At Initial Hospital Discharge  
     Home (with or without services) 490 (32%) 
     Inpatient rehab facility 408 (27%) 
     Skilled nursing facility 362 (24%) 
     Other † 278 (18%) 
MVC = motor vehicle collision; mL = milliliters; °F = degrees in Fahrenheit; mmHg = millimeters of 
mercury; bpm = beats per minute; g/dL = grams per deciliter; mEq/L = milliequivalents per liter; ED = 
emergency department; APACHE = Acute Physiology and Chronic Health Enquiry II 
* = American Indian, Asian, Pacific Islander, Other 
** = Moving vehicle collision – cyclist, struck by or against, pedestrian; falls; machinery injuries; other 
*** = Hypovolemic shock, sepsis, hypoxia, cardiac dysfunction, severe head injury (trauma only), 
withdrawal of life sustaining therapy, other †  = Nursing home, residential facility, against medical advice, another acute care facility, death or other 
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Table 5.2 Transfusion-Related Characteristics 
Transfused in first 6 hours (yes) Mean ± SD or n (%) 
     PRBC 1,411 (92%) 
     FFP 773 (50%) 
     PLT 395 (26%) 
Transfusion in first 24 hours (yes)  
     PRBC 1,536 (100%) 
     FFP 1,000 (65%) 
     PLT 618 (40%) 
Transfusion volume in first 6 hours  
     PRBC (mL) 1,977 ± 2,329 
                    Units 6.6 ± 7.8 
     FFP (mL) 705 ± 1,102 
                   Units 3.5 ± 5.5 
     PLT (mL) 125 ± 330 
                   Units 2.5 ± 6.6 
Transfusion volume in first 24 hours  
     PRBC (mL) 2,843 ± 3,599 
                 Units 9.5 ± 12 
     FFP (mL) 1,195 ± 1,899 
                 Units 6.0 ± 9.5 
     PLT (mL) 242 ± 486 
                Units 2.5 ± 6.6 
	  	   122 
Table 5.2, Cont. 
 
Ratios transfused components at 6 hours 
(units) 
 
     PRBC:FFP 1.9 ± 1.9 
     PRBC:PLT 1.9 ± 2.1 
Ratios transfused components at 24 hours 
(units) 
 
     PRBC:FFP 1.9 ± 2.0 
     PRBC:PLT 2.6 ± 2.9 
PRBC = packed red blood cells; PLT = platelets; FFP = fresh frozen plasma; mL = milliliters 
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Table 5.3 Inflammatory Complications (N = 1,538) 
Complication N (%) 
Multiple organ failure 1,163 (76%) 
Ventilator-associated pneumonia 421 (27%) 
Acute respiratory distress syndrome 371 (24%) 
Urinary tract infection 222 (14%) 
Septicemia 197 (13%) 
Catheter-related bloodstream infection 41 (3%) 
Nosocomial Infection 691 (45%) 
Organ failure based on Denver maximum score, categorized as those with a score of 1 or greater81 
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Table 5.4 Predictors of Development of Inflammatory Complications (n = 386) 
Variable (Reference Group) 𝜷 Exp  𝜷 95% CI P 
Age (years) .031 1.032 1.000 – 1.065 .053 
Sex (female) .571 1.769 .821 – 3.812 .145 
Comorbidities (none) 1.680 5.367 2.235 – 12.886 < .001 
NISS (≤ 24) .846 2.329 .648 – 8.366 .195 
24-hour transfused vol. PRBC units .079 1.083 1.018 – 1.151 .011 
24-hour transfused vol. PLT units .035 1.035 .943 – 1.136 .464 
PRBC:FFP (outside 0.5-1.5) .057 1.059 .478 – 2.344 .888 
PRBC:PLT (outside 0.5-1.5) -.300 .741 .297 – 1.850 .521 
Omnibus Tests of Model Coefficients p < 0.001; Hosmer and Lemeshow p = 0.241; NISS = New Injury 
Severity Score; PRBC = packed red blood cells; PLT = platelets; FFP = fresh frozen plasma. Comparison 
group for categorical variables provided in parentheses. 
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Table 5.5 Predictors of Time to Development of Inflammatory Complications (n = 
643) 
Variable (Reference Group) HR 95% CI P 
Age (years) .999 .992 – 1.005 .739 
Sex (female) 1.197 .998 – 1.436 .053 
Comorbidities (none) 1.163 .971 – 1.394 .101 
NISS (≤ 24) 1.409 1.034 – 1.920 .030 
24-hour transfused vol. PRBC units 1.010 1.004 – 1.016 .001 
24-hour transfused vol. PLT units 1.003 .994 – 1.011 .533 
PRBC:FFP (other than 0.5-1.5) 1.068 .900 – 1.267 .451 
PRBC:PLT (other than 0.5-1.5) .970 .809 – 1.164 .746 
Omnibus Tests of Model Coefficients p < 0.001; NISS = New Injury Severity Score; PRBC = packed red 
blood cells; PLT = platelets; FFP = fresh frozen plasma. Comparison group for categorical variables 
provided in parentheses. Approximately 12% of patients were censored. 
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Figure 5.1 Time to development of complications by PRBC:FFP ratio group 
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Figure 5.2 Time to development of complications by PRBC:PLT ratio group 
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Figure Legend 
Figure 5.1 Time to development of complications by PRBC:FFP ratio group 
Figure 5.2 Time to development of complications by PRBC:PLT ratio group 
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CHAPTER SIX 
 
Conclusion 
 The purpose of this dissertation was to evaluate outcomes associated with blood 
component transfusions in adult major trauma patients. Unintentional traumatic injury 
affects millions of people worldwide annually,(1) with many patients requiring 
transfusion of blood or blood components for resuscitation. Stored components 
experience biological and chemical alterations that result in a storage lesion.(2) Evidence 
exists to support an increased risk of complications and mortality in transfused trauma 
patients,(3) yet the relationship between the storage lesion and patient outcomes remains 
unclear.  
The first manuscript presented a conceptual model of the current state of 
knowledge regarding short- and long-term outcomes associated with trauma, hemorrhage, 
and transfusion, focusing on the consequences of the storage lesion. The second 
manuscript, a systematic review of the literature, focused on outcomes for massively 
transfused trauma patients based on the ratios of blood components they received during 
resuscitation. The third manuscript presented findings from a secondary analysis of the 
2009 National Trauma Data Bank (NTDB) data set, evaluating mortality likelihood for 
trauma patients who were transfused with whole blood compared with those who 
received blood components. The fourth manuscript presented findings from a secondary 
analysis of the Inflammation and Host Response to Injury Trauma Database (TRDB), in 
which the relationship between blood component transfusion and development of 
inflammatory complications was evaluated. 
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The short- and long-term outcomes of traumatic injury and subsequent 
hemorrhage have been thoroughly discussed in the literature.(4-7) However, a lack of 
evidence exists regarding both short- and long-term outcomes associated with the 
transfusion of blood components and the storage lesion, particularly in packed red blood 
cells (PRBCs) and platelets (PLTs). The second manuscript presented a conceptual model 
depicting the state of knowledge surrounding these issues, with specific focus on the 
pathophysiology of the storage lesion. Consequences of the storage lesion induce a 
systemic inflammatory response in the transfused patient, as well as vasoconstriction,(2) 
electrolyte imbalances, and acidosis,(8) and these effects only worsen with time. 
Particular attention to patient status following trauma and subsequent transfusion is 
indicated in anticipation of inflammatory reactions. Suggestions for future research in this 
area include prevention and development of specific inflammatory complications, 
hospital readmission rates, rehabilitation requirements, and cognitive dysfunction. 
Due to the damaging effects associated with transfusion of stored components, a 
systematic review of the literature was performed to evaluate outcomes of trauma patients 
who required massive transfusion (at least 10 units of PRBCs in a 24-hour period) based 
on the ratio of components transfused. This review consisted of 21 studies that were 
primarily retrospective in nature, and included both military and civilian populations. 
Risk of bias was evaluated using a 9-item instrument adapted from Viswanathan & 
Berkman.(9) Overall, the studies were found to have low risk of bias, but there were 
issues related to reporting of adverse events and outcomes, and controlling of 
confounding factors in the analyses. The main finding from review of the studies was that 
transfusion of components in a 1:1:1 ratio, or 1 unit of PRBCs to 1 unit of PLTs to 1 unit 
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of fresh frozen plasma (FFP), produced superior survival in massively transfused trauma 
patients. This ratio closely resembles the composition of whole blood, which 
investigators suggest may be the reason for its survival benefit. Results regarding the 
relationship of this ratio with complications during hospitalization were inconclusive and 
require further investigation.  
Findings from this systematic review led to an investigation of the NTDB to 
evaluate mortality likelihood for major trauma patients who received whole blood 
compared with those who received blood components. After controlling for age, gender, 
Injury Severity Score, emergency medical system transfer time, and transfer of the patient 
from another hospital, transfusion of blood components was found to be associated with a 
three-fold increase in mortality likelihood in trauma patients compared with transfusion 
of whole blood. However, whole blood transfusion is rare in the clinical setting outside of 
front-line military scenarios or in surgery. Our findings call into question the current 
standard of care for resuscitation of patients with major trauma, including the ubiquitous 
transfusion of blood components. The volume and age of the transfused stored 
components may have influenced these outcomes, thus further investigation is warranted.   
To explore further the notion that transfusion of components in a 1:1:1 fashion 
may be beneficial to trauma patients in terms of development of complications, the third 
manuscript presented findings from a secondary analysis of the TRDB. This database 
included only blunt trauma patients; from this sample, those who were critically injured 
and required blood component transfusion in the first 24 hours following hospital 
admission were selected. The investigation yielded several important findings. First, the 
vast majority of patients developed at least one inflammatory complication. Second, 
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though the volume of PRBCs transfused in the first 24 hours of hospitalization was 
associated with development of inflammatory complications, total transfused volume of 
FFP and PLT in the first 24 hours of hospitalization and the ratios of transfused 
components were not. Third, presence of at least one comorbidity increased likelihood of 
complication development.  
Two independent predictors of time to development of inflammatory 
complications were identified: the initial 24-hour total transfused volume of PRBCs and 
injury severity. Again, the total transfused volume of FFP and PLTs in the first 24 hours 
of care and the ratios of PRBCs:PLTs and PRBCs:FFP were not predictors of 
complications. Investigators have suggested that the timing of transfusions may have 
more impact than the volume or ratio of components transfused in massively transfused 
trauma patients,(10) providing an area of future inquiry for those non-massively 
transfused. It may also be the case that non-massively transfused trauma patients have 
different transfusion requirements based on their coagulopathic state. 
Thus, the findings of this dissertation support transfusion of components in a 
1:1:1 ratio for survival benefit in massively transfused trauma patients, but this may not 
apply to trauma patients requiring less than massive transfusion. Whole blood was found 
to be more beneficial for survival in major trauma patients, as well. However, this is not 
current standard of care for resuscitation, especially in the civilian setting. In blunt 
trauma patients, neither the volume of transfused components nor the ratio of transfused 
components was associated with development of inflammatory complications, despite 
over 85% of transfused patients developing at least one.  
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Limitations of this dissertation must be considered along with the findings. The 
studies included in the systematic review were primarily retrospective in nature, thereby 
restricting investigators’ abilities to control for factors that may influence patient 
outcomes. There was also great variability in the analyses performed by investigators and 
the confounding factors for which they controlled, thus limiting the generalizability of 
findings. The secondary analyses performed using the NTDB and the TRDB data were 
limited in terms of the data available for analysis. The NTDB, for example, did not 
include any data related to transfusion of FFP or volume of components/whole blood 
transfused, thereby limiting the analysis and findings. Neither database had data 
pertaining to age of stored components. Given that both data sets contained large 
numbers of transfused trauma patients, this information could have greatly supplemented 
both analyses. Finally, as with any retrospective analysis, missing data or incorrect data 
due to entry error poses a challenge, and the nature of a secondary analysis of 
deidentified data does not allow for determination of data validity.     
The most effective transfusion strategy for survival and development of 
complications in both massively and non-massively transfused trauma patients has yet to 
be determined. Further research is required to explore the consequences of the storage 
lesion in transfused trauma patients. Future studies focusing on outcomes in both the 
short-term and long-term may help guide evaluation and treatment of the trauma 
population. 
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